Oxidative	O
stress	O
triggers	O
STAT3	B-protein
tyrosine	O
phosphorylation	O
and	O
nuclear	O
translocation	O
in	O
human	B-cell_type
lymphocytes	I-cell_type
.	O

Oxidizing	O
agents	O
are	O
powerful	O
activators	O
of	O
factors	O
responsible	O
for	O
the	O
transcriptional	O
activation	O
of	O
cytokine-encoding	B-DNA
genes	I-DNA
involved	O
in	O
tissue	O
injury	O
.	O

In	O
this	O
study	O
we	O
show	O
evidence	O
that	O
STAT3	B-protein
is	O
a	O
transcription	B-protein
factor	I-protein
whose	O
activity	O
is	O
modulated	O
by	O
H2O2	O
in	O
human	B-cell_type
lymphocytes	I-cell_type
,	O
in	O
which	O
endogenous	O
catalase	B-protein
had	O
previously	O
been	O
inhibited	O
.	O

H2O2-induced	O
nuclear	O
translocation	O
of	O
STAT3	B-protein
to	O
form	O
sequence-specific	B-protein
DNA-bound	I-protein
complexes	I-protein
was	O
evidenced	O
by	O
immunoblotting	O
of	O
nuclear	O
fractions	O
and	O
electrophoretic	O
mobility	O
shift	O
assays	O
,	O
and	O
vanadate	O
was	O
found	O
to	O
strongly	O
synergize	O
with	O
H2O2	O
.	O

Moreover	O
,	O
anti-	O
STAT3	B-protein
antibodies	I-protein
specifically	O
precipitated	O
a	O
protein	O
of	O
92	B-protein
kDa	I-protein
that	O
becomes	O
phosphorylated	O
on	O
tyrosine	O
upon	O
lymphocyte	O
treatment	O
with	O
H2O2	O
.	O

Phenylarsine	O
oxide	O
,	O
a	O
tyrosine	O
phosphatase	O
inhibitor	O
,	O
and	O
genistein	O
,	O
a	O
tyrosine	O
kinase	O
inhibitor	O
,	O
cooperated	O
and	O
cancelled	O
,	O
respectively	O
,	O
the	O
H2O2-promoted	O
STAT3	B-protein
nuclear	O
translocation	O
.	O

Evidence	O
is	O
also	O
presented	O
,	O
using	O
Fe2+/Cu2+	O
ions	O
,	O
that.OH	O
generated	O
from	O
H2O2	O
through	O
Fenton	O
reactions	O
could	O
be	O
a	O
candidate	O
oxygen	O
reactive	O
species	O
to	O
directly	O
activate	O
STAT3	B-protein
.	O

Present	O
data	O
suggest	O
that	O
H2O2	O
and	O
vanadate	O
are	O
likely	O
to	O
inhibit	O
the	O
activity	O
of	O
intracellular	B-protein
tyrosine	I-protein
phosphatase	I-protein
(	O
s	O
)	O
,	O
leading	O
to	O
enhanced	O
STAT3	B-protein
tyrosine	O
phosphorylation	O
and	O
hence	O
its	O
translocation	O
to	O
the	O
nucleus	O
.	O

These	O
results	O
demonstrate	O
that	O
the	O
DNA	O
binding	O
activity	O
of	O
STAT3	B-protein
can	O
be	O
modulated	O
by	O
oxidizing	O
agents	O
and	O
provide	O
a	O
framework	O
to	O
understand	O
the	O
effects	O
of	O
oxidative	O
stress	O
on	O
the	O
JAK	B-protein
-STAT	B-protein
signaling	O
pathway	O
.	O

THE	NULL
JOURNAL	NULL
oF	NULL
BIOLOGICAL	NULL
CHEMISTRY	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

274	NULL
,	NULL
No	NULL
.	NULL

25	NULL
,	NULL
Issue	NULL
of	NULL
June	NULL
18	NULL
,	NULL
pp	NULL
.	NULL

17580-17586	NULL
,	NULL
1999	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
Oxidative	NULL
Stress	NULL
Triggers	NULL
STAT3	NULL
Tyrosine	NULL
Phosphorylation	NULL
and	NULL
Nuclear	NULL
Translocation	NULL
in	NULL
Human	NULL
Lymphocytes*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
January	NULL
20	NULL
,	NULL
1999	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
March	NULL
11	NULL
,	NULL
1999	NULL
)	NULL
Modesto	NULL
Carballo	NULL
$	NULL
,	NULL
Manuel	NULL
Conde	NULL
?	NULL

$	NULL
,	NULL
Rajaa	NULL
El	NULL
Bekay	NULL
}	NULL
,	NULL
Jose	NULL
Martin-Nieto§	NULL
,	NULL
Maria	NULL
Jesus	NULL
Camacho1	NULL
,	NULL
Javier	NULL
Monteseirin1	NULL
,	NULL
José	NULL
Conde	NULL
,	NULL
Francisco	NULL
J	NULL
.	NULL

Bedoya	NULL
?	NULL

,	NULL
and	NULL
Francisco	NULL
Sobrino	NULL
#	NULL
!	NULL

1	NULL
From	NULL
the	NULL
{	NULL
Departamento	NULL
de	NULL
Bioquimica	NULL
Médica	NULL
y	NULL
Biologia	NULL
Molecular	NULL
,	NULL
Facultad	NULL
de	NULL
Medicina	NULL
and	NULL
the	NULL
Departamento	NULL
de	NULL
Medicina	NULL
,	NULL
Servicio	NULL
Regional	NULL
de	NULL
Inmunologia	NULL
y	NULL
Alergia	NULL
,	NULL
Hospital	NULL
Universitario	NULL
Virgen	NULL
Macarena	NULL
,	NULL
Universidad	NULL
de	NULL
Sevilla	NULL
,	NULL
41009	NULL
Sevilla	NULL
,	NULL
and	NULL
the	NULL
§Division	NULL
de	NULL
Genética	NULL
,	NULL
Universidad	NULL
de	NULL
Alicante	NULL
,	NULL
Campus	NULL
Universitario	NULL
San	NULL
Vicente	NULL
,	NULL
03080	NULL
Alicante	NULL
,	NULL
Spain	NULL
Oxidizing	NULL
agents	NULL
are	NULL
powerful	NULL
activators	NULL
of	NULL
factors	NULL
responsible	NULL
for	NULL
the	NULL
transcriptional	NULL
activation	NULL
of	NULL
cyto-kine-encoding	NULL
genes	NULL
involved	NULL
in	NULL
tissue	NULL
injury	NULL
.	NULL

In	NULL
this	NULL
study	NULL
we	NULL
show	NULL
evidence	NULL
that	NULL
STAT3	NULL
is	NULL
a	NULL
transcription	NULL
factor	NULL
whose	NULL
activity	NULL
is	NULL
modulated	NULL
by	NULL
H	NULL
;	NULL
0	NULL
,	NULL
in	NULL
human	NULL
lymphocytes	NULL
,	NULL
in	NULL
which	NULL
endogenous	NULL
catalase	NULL
had	NULL
previously	NULL
been	NULL
inhibited	NULL
.	NULL

H,0	NULL
,	NULL
-induced	NULL
nuclear	NULL
translocation	NULL
of	NULL
STAT3	NULL
to	NULL
form	NULL
sequence-specific	NULL
DNA-bound	NULL
complexes	NULL
was	NULL
evidenced	NULL
by	NULL
immunoblotting	NULL
of	NULL
nuclear	NULL
fractions	NULL
and	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
,	NULL
and	NULL
vanadate	NULL
was	NULL
found	NULL
to	NULL
strongly	NULL
synergize	NULL
with	NULL
H,0	NULL
,	NULL
.	NULL

Moreover	NULL
,	NULL
anti-STAT3	NULL
antibodies	NULL
specifically	NULL
precipitated	NULL
a	NULL
protein	NULL
of	NULL
92	NULL
kDa	NULL
that	NULL
becomes	NULL
phosphorylated	NULL
on	NULL
tyrosine	NULL
upon	NULL
lymphocyte	NULL
treatment	NULL
with	NULL
H,0	NULL
,	NULL
.	NULL

Phenylarsine	NULL
oxide	NULL
,	NULL
a	NULL
tyrosine	NULL
phosphatase	NULL
inhibitor	NULL
,	NULL
and	NULL
genistein	NULL
,	NULL
a	NULL
tyrosine	NULL
kinase	NULL
inhibitor	NULL
,	NULL
cooperated	NULL
and	NULL
cancelled	NULL
,	NULL
respectively	NULL
,	NULL
the	NULL
H,0	NULL
,	NULL
-promoted	NULL
STAT3	NULL
nuclear	NULL
translocation	NULL
.	NULL

Evidence	NULL
is	NULL
also	NULL
presented	NULL
,	NULL
using	NULL
Fe	NULL
``	NULL
*/Cu	NULL
``	NULL
*	NULL
ions	NULL
,	NULL
that	NULL
'OH	NULL
generated	NULL
from	NULL
H	NULL
,	NULL
O	NULL
,	NULL
through	NULL
Fenton	NULL
reactions	NULL
could	NULL
be	NULL
a	NULL
candidate	NULL
oxygen	NULL
reactive	NULL
species	NULL
to	NULL
directly	NULL
activate	NULL
STAT3	NULL
.	NULL

Present	NULL
data	NULL
suggest	NULL
that	NULL
H	NULL
,	NULL
O	NULL
,	NULL
and	NULL
vanadate	NULL
are	NULL
likely	NULL
to	NULL
inhibit	NULL
the	NULL
activity	NULL
of	NULL
intracellular	NULL
tyrosine	NULL
phosphatase	NULL
(	NULL
s	NULL
)	NULL
,	NULL
leading	NULL
to	NULL
enhanced	NULL
STAT3	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
hence	NULL
its	NULL
translocation	NULL
to	NULL
the	NULL
nucleus	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
that	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
STAT3	NULL
can	NULL
be	NULL
modulated	NULL
by	NULL
oxidizing	NULL
agents	NULL
and	NULL
provide	NULL
a	NULL
framework	NULL
to	NULL
understand	NULL
the	NULL
effects	NULL
of	NULL
oxidative	NULL
stress	NULL
on	NULL
the	NULL
JAK-STAT	NULL
signaling	NULL
pathway	NULL
.	NULL

Oxidative	NULL
stress	NULL
is	NULL
characterized	NULL
by	NULL
high	NULL
intracellular	NULL
levels	NULL
of	NULL
reactive	NULL
oxygen	NULL
intermediates	NULL
(	NULL
ROI	NULL
)	NULL
,	NULL
which	NULL
may	NULL
function	NULL
as	NULL
*This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
Fondo	NULL
Investigaciones	NULL
Sanitarias	NULL
Grants	NULL
94/1484	NULL
and	NULL
97/1289	NULL
(	NULL
to	NULL
F.	NULL
S.	NULL
)	NULL
and	NULL
97/207	NULL
(	NULL
to	NULL
J.	NULL
C.	NULL
)	NULL
,	NULL
a	NULL
grant	NULL
from	NULL
the	NULL
Foundation	NULL
of	NULL
Sociedad	NULL
Espafiola	NULL
Alergia	NULL
Immunologia	NULL
Clinica	NULL
of	NULL
Spain	NULL
(	NULL
to	NULL
J.	NULL
M.	NULL
)	NULL
,	NULL
Grant	NULL
SAF	NULL
96/0205	NULL
from	NULL
the	NULL
Direccién	NULL
General	NULL
Inves-tigacion	NULL
Cientifica	NULL
Técnica	NULL
(	NULL
to	NULL
F.	NULL
J	NULL
.	NULL

B	NULL
.	NULL
)	NULL

,	NULL
a	NULL
grant	NULL
from	NULL
Consejeria	NULL
Salud	NULL
(	NULL
Junta	NULL
de	NULL
Andalucia	NULL
)	NULL
(	NULL
to	NULL
F.	NULL
S.	NULL
)	NULL
,	NULL
and	NULL
a	NULL
grant	NULL
from	NULL
Innogenetis	NULL
Diagnos-tica	NULL
y	NULL
Terapeutica	NULL
S.A.	NULL
from	NULL
Spain	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

|	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
Dept	NULL
.	NULL

de	NULL
Bioquimica	NULL
Médica	NULL
y	NULL
Biologia	NULL
Molecular	NULL
.	NULL

Facultad	NULL
de	NULL
Medicina	NULL
.	NULL

Avda	NULL
.	NULL

Pizjuin	NULL
4	NULL
,	NULL
41009	NULL
Sevilla	NULL
Spain	NULL
.	NULL

Fax	NULL
:	NULL
84-95-4907041	NULL
;	NULL
E-mail	NULL
:	NULL
fsobrino	NULL
@	NULL
cica.es	NULL
.	NULL

*The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
ROI	NULL
,	NULL
reactive	NULL
oxygen	NULL
intermediates	NULL
;	NULL
PAO	NULL
,	NULL
phenylarsine	NULL
oxide	NULL
;	NULL
JAK	NULL
,	NULL
Janus	NULL
kinase	NULL
;	NULL
PTK	NULL
,	NULL
protein-tyrosine	NULL
kinases	NULL
;	NULL
PTPase	NULL
,	NULL
protein-tyrosine	NULL
phosphatases	NULL
;	NULL
PMSF	NULL
,	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
;	NULL
PHA	NULL
,	NULL
phytohemagglutinin	NULL
;	NULL
PBL	NULL
,	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
;	NULL
PAGE	NULL
,	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
;	NULL
SIE	NULL
,	NULL
sis-inducible	NULL
element	NULL
.	NULL

17580	NULL
physiological	NULL
mediators	NULL
of	NULL
a	NULL
number	NULL
of	NULL
cellular	NULL
responses	NULL
by	NULL
acting	NULL
as	NULL
second	NULL
messengers	NULL
for	NULL
specific	NULL
signaling	NULL
pathways	NULL
(	NULL
1-3	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
ROI	NULL
have	NULL
been	NULL
implicated	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
clinical	NULL
conditions	NULL
,	NULL
including	NULL
rheumatoid	NULL
arthritis	NULL
and	NULL
other	NULL
autoimmune	NULL
diseases	NULL
(	NULL
4	NULL
,	NULL
5	NULL
)	NULL
,	NULL
and	NULL
can	NULL
also	NULL
play	NULL
a	NULL
role	NULL
as	NULL
tumor	NULL
promoters	NULL
(	NULL
6	NULL
)	NULL
.	NULL

H	NULL
,	NULL
O	NULL
;	NULL
as	NULL
well	NULL
as	NULL
superoxide	NULL
anions	NULL
(	NULL
03	NULL
)	NULL
have	NULL
traditionally	NULL
been	NULL
viewed	NULL
as	NULL
potent	NULL
microbicidal	NULL
agents	NULL
(	NULL
7	NULL
)	NULL
.	NULL

H	NULL
;	NULL
0	NULL
,	NULL
is	NULL
a	NULL
small	NULL
,	NULL
diffusible	NULL
,	NULL
and	NULL
ubiquitous	NULL
molecule	NULL
that	NULL
can	NULL
be	NULL
rapidly	NULL
synthesized	NULL
,	NULL
as	NULL
well	NULL
as	NULL
destroyed	NULL
,	NULL
in	NULL
response	NULL
to	NULL
several	NULL
stimuli	NULL
.	NULL

It	NULL
has	NULL
been	NULL
proposed	NULL
that	NULL
is	NULL
converted	NULL
into	NULL
highly	NULL
reactive	NULL
'OH	NULL
radical	NULL
via	NULL
Fenton	NULL
chemistry	NULL
through	NULL
its	NULL
reduction	NULL
by	NULL
ferrous/cuprous	NULL
ions	NULL
(	NULL
8	NULL
,	NULL
9	NULL
)	NULL
.	NULL

H	NULL
,	NULL
O	NULL
,	NULL
fulfills	NULL
the	NULL
prerequisites	NULL
for	NULL
intracellular	NULL
second	NULL
messengers	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
recent	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
exposure	NULL
of	NULL
lymphocytes	NULL
to	NULL
oxidants	NULL
,	NULL
such	NULL
as	NULL
H	NULL
,	NULL
O	NULL
,	NULL
(	NULL
10-12	NULL
)	NULL
,	NULL
diamide	NULL
(	NULL
12	NULL
,	NULL
13	NULL
)	NULL
,	NULL
or	NULL
phenylarsine	NULL
oxide	NULL
(	NULL
PAO	NULL
)	NULL
(	NULL
14-16	NULL
)	NULL
,	NULL
results	NULL
in	NULL
an	NULL
increased	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
intracellular	NULL
proteins	NULL
.	NULL

STATs	NULL
(	NULL
signal	NULL
transducers	NULL
and	NULL
activators	NULL
of	NULL
transcription	NULL
)	NULL
are	NULL
a	NULL
class	NULL
of	NULL
transcription	NULL
factors	NULL
bearing	NULL
SH2	NULL
domains	NULL
that	NULL
become	NULL
activated	NULL
upon	NULL
tyrosine	NULL
phosphorylation	NULL
.	NULL

STATs	NULL
are	NULL
often	NULL
activated	NULL
by	NULL
members	NULL
of	NULL
the	NULL
JAK	NULL
family	NULL
of	NULL
protein-tyrosine	NULL
kinases	NULL
(	NULL
PTKs	NULL
)	NULL
in	NULL
response	NULL
to	NULL
cytokine	NULL
stimulation	NULL
.	NULL

This	NULL
activation	NULL
mechanism	NULL
involves	NULL
the	NULL
SH2	NULL
domain-dependent	NULL
recruitment	NULL
of	NULL
the	NULL
STATs	NULL
to	NULL
tyrosine-phosphorylated	NULL
cytokine	NULL
receptors	NULL
.	NULL

The	NULL
STAT	NULL
's	NULL
then	NULL
become	NULL
phosphorylated	NULL
by	NULL
receptor-associated	NULL
JAKs	NULL
,	NULL
which	NULL
induces	NULL
their	NULL
dimerization	NULL
via	NULL
reciprocal	NULL
SH2-phosphotyrosine	NULL
interaction	NULL
.	NULL

STAT	NULL
dimers	NULL
then	NULL
enter	NULL
the	NULL
nucleus	NULL
and	NULL
bind	NULL
to	NULL
specific	NULL
DNA	NULL
elements	NULL
,	NULL
thereby	NULL
activating	NULL
the	NULL
transcription	NULL
of	NULL
a	NULL
number	NULL
of	NULL
genes	NULL
.	NULL

The	NULL
JAK-STAT	NULL
pathway	NULL
has	NULL
been	NULL
the	NULL
subject	NULL
of	NULL
many	NULL
recent	NULL
comprehensive	NULL
reviews	NULL
(	NULL
17-21	NULL
)	NULL
.	NULL

STAT3	NULL
,	NULL
a	NULL
well	NULL
characterized	NULL
92-kDa	NULL
protein	NULL
,	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
become	NULL
activated	NULL
by	NULL
both	NULL
epidermal	NULL
growth	NULL
factor	NULL
and	NULL
interleukin-6	NULL
in	NULL
human	NULL
A-431	NULL
cells	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Because	NULL
the	NULL
ROI	NULL
generated	NULL
in	NULL
response	NULL
to	NULL
various	NULL
external	NULL
stimuli	NULL
can	NULL
play	NULL
a	NULL
role	NULL
both	NULL
as	NULL
regulators	NULL
of	NULL
transcription	NULL
factors	NULL
,	NULL
including	NULL
nuclear	NULL
factors	NULL
«	NULL
B	NULL
(	NULL
2	NULL
,	NULL
23	NULL
)	NULL
and	NULL
AT	NULL
(	NULL
24	NULL
)	NULL
,	NULL
and	NULL
as	NULL
inhibitors	NULL
of	NULL
protein-tyrosine	NULL
phosphatases	NULL
(	NULL
PTPases	NULL
)	NULL
(	NULL
25-27	NULL
)	NULL
,	NULL
we	NULL
have	NULL
investigated	NULL
whether	NULL
H	NULL
,	NULL
O	NULL
,	NULL
and	NULL
other	NULL
oxidizing	NULL
agents	NULL
could	NULL
modulate	NULL
STAT3	NULL
function	NULL
in	NULL
human	NULL
lymphocytes	NULL
.	NULL

Enhanced	NULL
phosphotyrosine	NULL
accumulation	NULL
could	NULL
then	NULL
result	NULL
from	NULL
the	NULL
combined	NULL
effects	NULL
of	NULL
increased	NULL
phosphorylation	NULL
and	NULL
decreased	NULL
de-phosphorylation	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
STAT	NULL
's	NULL
is	NULL
known	NULL
to	NULL
depend	NULL
primarily	NULL
on	NULL
tyrosine	NULL
phosphorylation	NULL
(	NULL
19	NULL
,	NULL
28-31	NULL
)	NULL
,	NULL
although	NULL
serine	NULL
phosphorylation	NULL
is	NULL
also	NULL
important	NULL
in	NULL
modulating	NULL
the	NULL
binding	NULL
affinity	NULL
of	NULL
STAT3	NULL
(	NULL
32-34	NULL
)	NULL
.	NULL

Here	NULL
we	NULL
show	NULL
for	NULL
the	NULL
first	NULL
time	NULL
that	NULL
STAT3	NULL
is	NULL
phosphorylated	NULL
on	NULL
tyrosine	NULL
residue	NULL
(	NULL
s	NULL
)	NULL
,	NULL
translocated	NULL
to	NULL
the	NULL
nucleus	NULL
,	NULL
and	NULL
elicited	NULL
to	NULL
bind	NULL
to	NULL
specific	NULL
DNA	NULL
elements	NULL
upon	NULL
lymphocyte	NULL
treatment	NULL
with	NULL
H,0	NULL
,	NULL
.	NULL

An	NULL
additive	NULL
effect	NULL
between	NULL
H	NULL
,	NULL
O	NULL
,	NULL
and	NULL
vanadate	NULL
was	NULL
also	NULL
evidenced	NULL
suggesting	NULL
that	NULL
inhibition	NULL
of	NULL
tyrosine	NULL
phosphatase	NULL
(	NULL
s	NULL
)	NULL
This	NULL
paper	NULL
is	NULL
available	NULL
on	NULL
line	NULL
at	NULL
http	NULL
:	NULL
//www.jbc.org	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
Oxidative	NULL
Stress	NULL
Activates	NULL
Lymphocyte	NULL
STAT3	NULL
17581	NULL
A	NULL
B	NULL
im	NULL
:	NULL
py	NULL
IP	NULL
:	NULL
STAT3	NULL
H,0	NULL
,	NULL
-	NULL
+	NULL
o	NULL
<	NULL
-	NULL
STAT3	NULL
BLOT	NULL
:	NULL
PY	NULL
mass	NULL
.	NULL

(	NULL
wl	NULL
BLOT	NULL
:	NULL
STAT3	NULL
H,0	NULL
;	NULL
nll	NULL
T5	NULL
»	NULL
In	NULL
220	NULL
97-	NULL
e	NULL
<	NULL
-	NULL
STATE	NULL
67-43-~_	NULL
1	NULL
2	NULL
3	NULL
4	NULL
BLOT	NULL
:	NULL
PY	NULL
STAT3	NULL
Fic	NULL
.	NULL

1	NULL
.	NULL

H	NULL
,	NULL
O	NULL
,	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT3	NULL
in	NULL
human	NULL
lymphocytes	NULL
.	NULL

A	NULL
,	NULL
PBL	NULL
were	NULL
left	NULL
untreated	NULL
(	NULL
-	NULL
)	NULL
or	NULL
were	NULL
treated	NULL
(	NULL
+	NULL
)	NULL
with	NULL
2	NULL
mM	NULL
H	NULL
,	NULL
O	NULL
,	NULL
for	NULL
2	NULL
min	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
at	NULL
37	NULL
°C	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
lysed	NULL
in	NULL
buffer	NULL
B	NULL
,	NULL
and	NULL
the	NULL
supernatants	NULL
obtained	NULL
after	NULL
centrifugation	NULL
were	NULL
incubated	NULL
with	NULL
anti-STAT3	NULL
antibodies	NULL
followed	NULL
by	NULL
precipitation	NULL
of	NULL
the	NULL
immune	NULL
complexes	NULL
with	NULL
protein	NULL
A-Sepharose	NULL
beads	NULL
.	NULL

The	NULL
bound	NULL
proteins	NULL
were	NULL
resolved	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
membranes	NULL
,	NULL
and	NULL
immunoblotted	NULL
sequentially	NULL
with	NULL
anti-phosphotyrosine	NULL
antibodies	NULL
(	NULL
upper	NULL
panel	NULL
)	NULL
or	NULL
after	NULL
stripping	NULL
with	NULL
anti-STAT3	NULL
antibodies	NULL
(	NULL
fower	NULL
panel	NULL
)	NULL
.	NULL

B	NULL
,	NULL
PBL	NULL
were	NULL
treated	NULL
and	NULL
lysed	NULL
as	NULL
in	NULL
A	NULL
,	NULL
and	NULL
immunoprecipitation	NULL
was	NULL
carried	NULL
out	NULL
with	NULL
anti-phosphotyrosine	NULL
antibodies	NULL
cross-linked	NULL
to	NULL
protein	NULL
A-agarose	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
was	NULL
detected	NULL
by	NULL
immunoblotting	NULL
with	NULL
anti-phosphotyrosine	NULL
antibodies	NULL
,	NULL
and	NULL
after	NULL
blot	NULL
stripping	NULL
,	NULL
STATS	NULL
protein	NULL
levels	NULL
were	NULL
analyzed	NULL
by	NULL
immunoblotting	NULL
with	NULL
anti-STAT3	NULL
antibodies	NULL
.	NULL

The	NULL
sizes	NULL
of	NULL
molecular	NULL
mass	NULL
markers	NULL
,	NULL
expressed	NULL
in	NULL
kDa	NULL
,	NULL
are	NULL
indicated	NULL
at	NULL
the	NULL
left	NULL
of	NULL
panel	NULL
B	NULL
.	NULL

Arrows	NULL
in	NULL
A	NULL
and	NULL
B	NULL
show	NULL
the	NULL
position	NULL
of	NULL
migration	NULL
of	NULL
STAT3	NULL
.	NULL

IP	NULL
,	NULL
immunoprecipitation	NULL
;	NULL
PY	NULL
,	NULL
phosphotyrosine	NULL
.	NULL

by	NULL
pervanadate	NULL
could	NULL
take	NULL
place	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
H	NULL
,	NULL
O	NULL
;	NULL
were	NULL
also	NULL
enhanced	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
Fe®*	NULL
and	NULL
Cu®*	NULL
ions	NULL
,	NULL
which	NULL
indicates	NULL
the	NULL
participation	NULL
of	NULL
other	NULL
chemical	NULL
reactive	NULL
species	NULL
derived	NULL
from	NULL
oxygen	NULL
.	NULL

These	NULL
data	NULL
collectively	NULL
indicate	NULL
that	NULL
STAT3	NULL
is	NULL
a	NULL
major	NULL
component	NULL
of	NULL
the	NULL
signaling	NULL
pathways	NULL
that	NULL
become	NULL
activated	NULL
by	NULL
oxidative	NULL
stress	NULL
in	NULL
human	NULL
lymphocytes	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Reagents-Hydrogen	NULL
peroxide	NULL
(	NULL
80	NULL
%	NULL
,	NULL
v/v	NULL
)	NULL
,	NULL
S-amino-1,2,4-triazole	NULL
,	NULL
Na	NULL
,	NULL
VO	NULL
,	NULL
,	NULL
PAO	NULL
,	NULL
diamide	NULL
,	NULL
genistein	NULL
,	NULL
fetal	NULL
bovine	NULL
serum	NULL
,	NULL
and	NULL
1,10-phenantroline	NULL
were	NULL
purchased	NULL
from	NULL
Sigma	NULL
Chemical	NULL
(	NULL
Madrid	NULL
,	NULL
Spain	NULL
)	NULL
.	NULL

Ficoll-Hypaque	NULL
,	NULL
phosphate-buffered	NULL
saline	NULL
,	NULL
and	NULL
RPMI	NULL
1640	NULL
were	NULL
obtained	NULL
from	NULL
Bio-Whittaker	NULL
(	NULL
Verviers	NULL
,	NULL
Belgium	NULL
)	NULL
.	NULL

Phenylmethylsulfonyl	NULL
fluoride	NULL
(	NULL
PMSF	NULL
)	NULL
and	NULL
the	NULL
double-stranded	NULL
SIE	NULL
m67	NULL
oligonucleotide	NULL
(	NULL
5'-GTCGA-CATTTCCCGTAAATC-3	NULL
'	NULL
)	NULL
were	NULL
obtained	NULL
from	NULL
Roche	NULL
Molecular	NULL
Biochemicals	NULL
(	NULL
Barcelona	NULL
,	NULL
Spain	NULL
)	NULL
.	NULL

Interferon-a	NULL
was	NULL
purchased	NULL
from	NULL
Scher-ing-Plow	NULL
(	NULL
Brinny	NULL
Innishannon	NULL
,	NULL
Ireland	NULL
)	NULL
.	NULL

Antibodies-Polyclonal	NULL
antisera	NULL
directed	NULL
against	NULL
STAT1	NULL
and	NULL
STAT3	NULL
were	NULL
purchased	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
(	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Monoclonal	NULL
antibodies	NULL
(	NULL
4G10	NULL
)	NULL
against	NULL
phosphotyrosine	NULL
(	NULL
free	NULL
or	NULL
conjugated	NULL
to	NULL
agarose	NULL
beads	NULL
)	NULL
were	NULL
purchased	NULL
from	NULL
Upstate	NULL
Biotechnology	NULL
,	NULL
Inc.	NULL
(	NULL
Lake	NULL
Placid	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

Polyclonal	NULL
anti-STAT5B	NULL
antibody	NULL
was	NULL
kindly	NULL
provided	NULL
by	NULL
Dr.	NULL
J.	NULL
O'Shea	NULL
(	NULL
Bethesda	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

Goat	NULL
anti-rabbit	NULL
and	NULL
anti-mouse	NULL
antibodies	NULL
conjugated	NULL
to	NULL
horseradish	NULL
peroxidase	NULL
were	NULL
purchased	NULL
from	NULL
Sigma	NULL
Chemical	NULL
.	NULL

Cell	NULL
Culture	NULL
and	NULL
Treatment-Human	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
(	NULL
PBL	NULL
)	NULL
were	NULL
prepared	NULL
by	NULL
Ficoll-Hypaque	NULL
gradient	NULL
centrifugation	NULL
from	NULL
normal	NULL
blood	NULL
donors	NULL
,	NULL
following	NULL
informed	NULL
consent	NULL
.	NULL

Normally	NULL
,	NULL
PBL	NULL
were	NULL
used	NULL
immediately	NULL
after	NULL
they	NULL
were	NULL
obtained	NULL
.	NULL

In	NULL
other	NULL
cases	NULL
,	NULL
PBL	NULL
were	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
fetal	NULL
bovine	NULL
serum	NULL
,	NULL
2	NULL
mM	NULL
L-glutamine	NULL
,	NULL
100	NULL
units/ml	NULL
penicillin	NULL
,	NULL
and	NULL
100	NULL
ug/ml	NULL
streptomycin	NULL
and	NULL
maintained	NULL
at	NULL
37	NULL
°C	NULL
in	NULL
an	NULL
atmosphere	NULL
of	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
and	NULL
95	NULL
%	NULL
O	NULL
,	NULL
for	NULL
24	NULL
h.	NULL
For	NULL
stimulation	NULL
treatments	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
washed	NULL
with	NULL
RPMI	NULL
1640	NULL
,	NULL
resuspended	NULL
in	NULL
fresh	NULL
medium	NULL
at	NULL
a	NULL
density	NULL
of	NULL
10	NULL
x	NULL
10°	NULL
cells/ml	NULL
,	NULL
and	NULL
incubated	NULL
in	NULL
RPMI	NULL
1640	NULL
with	NULL
the	NULL
reagents	NULL
indicated	NULL
in	NULL
each	NULL
case	NULL
and	NULL
for	NULL
the	NULL
specified	NULL
times	NULL
at	NULL
37	NULL
°C	NULL
.	NULL

Stimulation	NULL
was	NULL
terminated	NULL
by	NULL
centrifugation	NULL
at	NULL
5,000	NULL
rpm	NULL
for	NULL
30	NULL
s	NULL
and	NULL
washing	NULL
once	NULL
with	NULL
ice-cold	NULL
phosphate-buffered	NULL
saline	NULL
supplemented	NULL
with	NULL
400	NULL
uM	NULL
Na	NULL
,	NULL
VO	NULL
,	NULL
and	NULL
400	NULL
pM	NULL
EDTA	NULL
.	NULL

In	NULL
all	NULL
the	NULL
experiments	NULL
in	NULL
which	NULL
H,0	NULL
,	NULL
was	NULL
used	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
previously	NULL
incubated	NULL
with	NULL
25	NULL
mM	NULL
aminotriazole	NULL
for	NULL
80	NULL
min	NULL
to	NULL
inhibit	NULL
endogenous	NULL
catalase	NULL
activity	NULL
,	NULL
and	NULL
the	NULL
cells	NULL
were	NULL
not	NULL
washed	NULL
before	NULL
H	NULL
,	NULL
O	NULL
,	NULL
addition	NULL
.	NULL

Western	NULL
Blotting	NULL
Analysis-Stimulated	NULL
cells	NULL
were	NULL
pelleted	NULL
and	NULL
lysed	NULL
in	NULL
75	NULL
pl	NULL
of	NULL
ice-cold	NULL
lysis	NULL
buffer	NULL
A	NULL
,	NULL
containing	NULL
20	NULL
mM	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
8.0	NULL
,	NULL
1	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
Nonidet	NULL
P-40	NULL
,	NULL
187	NULL
mM	NULL
NaCl	NULL
,	NULL
5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
and	NULL
the	NULL
following	NULL
inhibitors	NULL
of	NULL
phosphatase	NULL
and	NULL
protease	NULL
:	NULL
5	NULL
mM	NULL
EDTA	NULL
,	NULL
100	NULL
uM	NULL
PAO	NULL
,	NULL
1	NULL
mM	NULL
Na	NULL
,	NULL
VO	NULL
,	NULL
,	NULL
10	NULL
ug/ml	NULL
!	NULL

aprotinin	NULL
,	NULL
10	NULL
ug/ml	NULL
leupeptin	NULL
,	NULL
and	NULL
1	NULL
mM	NULL
PMSF	NULL
.	NULL

The	NULL
lysates	NULL
were	NULL
kept	NULL
on	NULL
ice	NULL
for	NULL
30	NULL
min	NULL
with	NULL
occasional	NULL
mixing	NULL
and	NULL
then	NULL
centrifuged	NULL
at	NULL
10,000	NULL
x	NULL
g	NULL
for	NULL
10	NULL
min	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

The	NULL
supernatants	NULL
obtained	NULL
constituted	NULL
the	NULL
cytoplasmic	NULL
fraction	NULL
,	NULL
and	NULL
the	NULL
nuclei-containing	NULL
pellets	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
buffer	NULL
A	NULL
(	NULL
85	NULL
)	NULL
.	NULL

Standard	NULL
Laemmli	NULL
sample	NULL
buffer	NULL
was	NULL
then	NULL
added	NULL
to	NULL
cytosolic	NULL
and	NULL
nuclear	NULL
fractions	NULL
,	NULL
and	NULL
after	NULL
boiling	NULL
for	NULL
5	NULL
min	NULL
followed	NULL
by	NULL
centrifugation	NULL
at	NULL
10,000	NULL
x	NULL
g	NULL
for	NULL
10	NULL
min	NULL
,	NULL
the	NULL
supernatants	NULL
were	NULL
analyzed	NULL
by	NULL
SDS-PAGE	NULL
on	NULL
7.5	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
.	NULL

The	NULL
separated	NULL
proteins	NULL
were	NULL
electrophoretically	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
membranes	NULL
,	NULL
and	NULL
after	NULL
blocking	NULL
nonspecific	NULL
interactions	NULL
in	NULL
TBST	NULL
(	NULL
150	NULL
mM	NULL
NaCl	NULL
,	NULL
50	NULL
mM	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
0.1	NULL
%	NULL
Tween	NULL
20	NULL
)	NULL
containing	NULL
3	NULL
%	NULL
bovine	NULL
serum	NULL
albumin	NULL
for	NULL
1	NULL
h	NULL
,	NULL
incubation	NULL
with	NULL
anti-STAT	NULL
or	NULL
4G1O	NULL
antibodies	NULL
(	NULL
diluted	NULL
1:1000	NULL
in	NULL
TBST	NULL
)	NULL
was	NULL
carried	NULL
out	NULL
overnight	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

Next	NULL
,	NULL
the	NULL
membranes	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
TBST	NULL
,	NULL
and	NULL
incubation	NULL
with	NULL
a	NULL
1:5000	NULL
dilution	NULL
of	NULL
goat	NULL
anti-rabbit	NULL
secondary	NULL
antibody	NULL
coupled	NULL
to	NULL
horseradish	NULL
peroxidase	NULL
was	NULL
performed	NULL
for	NULL
1	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

After	NULL
washing	NULL
three	NULL
times	NULL
with	NULL
TBST	NULL
,	NULL
immunore-active	NULL
bands	NULL
were	NULL
visualized	NULL
by	NULL
using	NULL
the	NULL
enhanced	NULL
chemiluminescence	NULL
assay	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
86	NULL
)	NULL
.	NULL

Immunoprecipitation-Stimulated	NULL
cells	NULL
were	NULL
pelleted	NULL
and	NULL
lysed	NULL
in	NULL
75	NULL
ul	NULL
of	NULL
ice-cold	NULL
lysis	NULL
buffer	NULL
B	NULL
containing	NULL
50	NULL
mM	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
300	NULL
mM	NULL
NaCl	NULL
,	NULL
100	NULL
um	NULL
PAO	NULL
,	NULL
10	NULL
ug/ml	NULL
leupeptin	NULL
,	NULL
10	NULL
ug/ml	NULL
aprotinin	NULL
,	NULL
1	NULL
mM	NULL
PMSF	NULL
,	NULL
1	NULL
mM	NULL
Na	NULL
,	NULL
VO	NULL
,	NULL
,	NULL
and	NULL
5	NULL
mM	NULL
EDTA	NULL
.	NULL

The	NULL
lysates	NULL
were	NULL
centrifuged	NULL
at	NULL
12,000	NULL
x	NULL
g	NULL
for	NULL
5	NULL
min	NULL
.	NULL

For	NULL
immunoprecipitation	NULL
,	NULL
incubation	NULL
with	NULL
anti-STAT3	NULL
specific	NULL
antibodies	NULL
(	NULL
0.5	NULL
ug/70	NULL
ul	NULL
)	NULL
was	NULL
carried	NULL
out	NULL
with	NULL
rotation	NULL
for	NULL
2	NULL
h	NULL
at	NULL
4	NULL
°C	NULL
,	NULL
followed	NULL
by	NULL
addition	NULL
of	NULL
40	NULL
ul	NULL
of	NULL
a	NULL
(	NULL
50	NULL
%	NULL
)	NULL
slurry	NULL
of	NULL
protein	NULL
A-Sepharose	NULL
beads	NULL
and	NULL
further	NULL
incubation	NULL
for	NULL
2	NULL
h	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

Alternatively	NULL
,	NULL
anti-phosphotyrosine	NULL
antibodies	NULL
covalently	NULL
attached	NULL
to	NULL
agarose	NULL
(	NULL
10	NULL
ug/70	NULL
ul	NULL
)	NULL
and	NULL
a	NULL
single	NULL
incubation	NULL
step	NULL
performed	NULL
for	NULL
2	NULL
h	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

The	NULL
immune	NULL
complexes	NULL
were	NULL
washed	NULL
five	NULL
times	NULL
with	NULL
ice-cold	NULL
lysis	NULL
buffer	NULL
B	NULL
,	NULL
and	NULL
the	NULL
proteins	NULL
were	NULL
extracted	NULL
by	NULL
boiling	NULL
the	NULL
pellet	NULL
in	NULL
standard	NULL
Laemmli	NULL
sample	NULL
buffer	NULL
.	NULL

After	NULL
resolution	NULL
by	NULL
SDS-PAGE	NULL
(	NULL
7.5	NULL
%	NULL
polyacrylamide	NULL
)	NULL
,	NULL
the	NULL
proteins	NULL
were	NULL
electrotransferred	NULL
to	NULL
nitrocellulose	NULL
membranes	NULL
and	NULL
subjected	NULL
to	NULL
immunoblotting	NULL
analysis	NULL
as	NULL
indicated	NULL
above	NULL
.	NULL

Electrophoretic	NULL
Mobility	NULL
Shift	NULL
Assay-Stimulated	NULL
cells	NULL
were	NULL
lysed	NULL
on	NULL
ice	NULL
for	NULL
10	NULL
min	NULL
in	NULL
hypotonic	NULL
buffer	NULL
C	NULL
,	NULL
which	NULL
contained	NULL
20	NULL
mM	NULL
HEPES	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
10	NULL
mM	NULL
KCl	NULL
,	NULL
1	NULL
mM	NULL
Na	NULL
,	NULL
VO	NULL
,	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
1	NULL
mM	NULL
PMSF	NULL
,	NULL
10	NULL
ug/ml	NULL
aprotinin	NULL
,	NULL
10	NULL
ug/ml	NULL
leupeptin	NULL
,	NULL
20	NULL
mM	NULL
NaF	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
and	NULL
0.2	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
Nonidet	NULL
P-40	NULL
.	NULL

After	NULL
centrifugation	NULL
at	NULL
18,000	NULL
rpm	NULL
for	NULL
1	NULL
min	NULL
at	NULL
4	NULL
°C	NULL
,	NULL
the	NULL
supernatant	NULL
obtained	NULL
was	NULL
collected	NULL
as	NULL
the	NULL
cytoplasmic	NULL
fraction	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
by	NULL
resuspension	NULL
of	NULL
the	NULL
pellet	NULL
in	NULL
25	NULL
pl	NULL
of	NULL
high	NULL
salt	NULL
buffer	NULL
(	NULL
buffer	NULL
C	NULL
supplemented	NULL
with	NULL
20	NULL
%	NULL
glycerol	NULL
and	NULL
420	NULL
mM	NULL
NaC	NULL
)	NULL
)	NULL
,	NULL
followed	NULL
by	NULL
incubation	NULL
on	NULL
ice	NULL
for	NULL
80	NULL
min	NULL
with	NULL
occasional	NULL
mixing	NULL
.	NULL

After	NULL
centrifugation	NULL
at	NULL
18,000	NULL
rpm	NULL
for	NULL
10	NULL
min	NULL
at	NULL
4°C	NULL
,	NULL
the	NULL
supernatants	NULL
obtained	NULL
constituted	NULL
the	NULL
nuclear	NULL
extracts	NULL
.	NULL

STAT3	NULL
DNA	NULL
binding	NULL
activity	NULL
was	NULL
assayed	NULL
using	NULL
the	NULL
SIE	NULL
m67	NULL
20-base	NULL
pair	NULL
oligonucleotide	NULL
as	NULL
a	NULL
probe	NULL
(	NULL
see	NULL
sequence	NULL
above	NULL
)	NULL
and	NULL
the	NULL
digoxigenin	NULL
gel	NULL
shift	NULL
assay	NULL
kit	NULL
from	NULL
Roche	NULL
Molecular	NULL
Biochemicals	NULL
.	NULL

The	NULL
reactions	NULL
were	NULL
performed	NULL
in	NULL
15	NULL
ul	NULL
of	NULL
a	NULL
binding	NULL
buffer	NULL
containing	NULL
20	NULL
mM	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
7.8	NULL
,	NULL
50	NULL
my	NULL
KCl	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
0.1	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
Nonidet	NULL
P-40	NULL
,	NULL
6	NULL
%	NULL
glycerol	NULL
,	NULL
and	NULL
10	NULL
ug	NULL
of	NULL
nuclear	NULL
extract	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
1	NULL
pmol	NULL
of	NULL
digoxigenin-labeled	NULL
oligonucleotide	NULL
and	NULL
allowed	NULL
to	NULL
proceed	NULL
for	NULL
20	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

For	NULL
competition	NULL
assays	NULL
,	NULL
binding	NULL
reactions	NULL
were	NULL
performed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
17582	NULL
oligonucleotide	NULL
.	NULL

The	NULL
samples	NULL
were	NULL
finally	NULL
electrophoresed	NULL
on	NULL
5	NULL
%	NULL
polyacrylamide	NULL
native	NULL
gels	NULL
at	NULL
4	NULL
°C	NULL
in	NULL
0.25	NULL
%	NULL
TBE	NULL
buffer	NULL
.	NULL

RESULTS	NULL
Hydrogen	NULL
Peroxide	NULL
Promotes	NULL
Tyrosine	NULL
Phosphorylation	NULL
and	NULL
Nuclear	NULL
Translocation	NULL
of	NULL
STAT3-To	NULL
investigate	NULL
the	NULL
changes	NULL
on	NULL
the	NULL
STAT3	NULL
tyrosine	NULL
phosphorylation	NULL
status	NULL
that	NULL
take	NULL
place	NULL
under	NULL
oxidative	NULL
stress	NULL
conditions	NULL
,	NULL
PBL	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
H	NULL
;	NULL
0	NULL
,	NULL
for	NULL
2	NULL
min	NULL
,	NULL
and	NULL
then	NULL
STAT3	NULL
was	NULL
immunoprecipitated	NULL
using	NULL
specific	NULL
antibodies	NULL
.	NULL

Immunoblotting	NULL
analyses	NULL
revealed	NULL
that	NULL
,	NULL
whereas	NULL
the	NULL
amount	NULL
of	NULL
STAT3	NULL
protein	NULL
immunoprecipitated	NULL
from	NULL
H,0	NULL
,	NULL
-treated	NULL
and	NULL
untreated	NULL
cells	NULL
was	NULL
comparable	NULL
,	NULL
the	NULL
phosphotyrosine	NULL
content	NULL
of	NULL
STAT3	NULL
was	NULL
considerably	NULL
higher	NULL
in	NULL
lymphocytes	NULL
treated	NULL
with	NULL
H	NULL
;	NULL
0	NULL
,	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

In	NULL
other	NULL
experi-ments	NULL
,	NULL
cells	NULL
treated	NULL
with	NULL
H	NULL
;	NULL
0	NULL
;	NULL
and	NULL
untreated	NULL
control	NULL
cells	NULL
were	NULL
lysed	NULL
and	NULL
subjected	NULL
to	NULL
immunoprecipitation	NULL
with	NULL
anti-phosphotyrosine	NULL
antibodies	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
a	NULL
high	NULL
number	NULL
of	NULL
proteins	NULL
underwent	NULL
tyrosine	NULL
phosphorylation	NULL
upon	NULL
H	NULL
;	NULL
0	NULL
,	NULL
treat-ment	NULL
,	NULL
as	NULL
revealed	NULL
by	NULL
immunoblotting	NULL
using	NULL
the	NULL
same	NULL
anti-phosphotyrosine	NULL
antibodies	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
STAT3	NULL
as	NULL
a	NULL
92-kDa	NULL
protein	NULL
among	NULL
these	NULL
phosphorylated	NULL
polypeptides	NULL
was	NULL
further	NULL
evidenced	NULL
by	NULL
immunobloting	NULL
with	NULL
anti-STAT3	NULL
antibodies	NULL
.	NULL

A	NULL
detectable	NULL
signal	NULL
was	NULL
only	NULL
obtained	NULL
in	NULL
the	NULL
immunopre-cipitates	NULL
from	NULL
cells	NULL
treated	NULL
with	NULL
which	NULL
was	NULL
virtually	NULL
absent	NULL
in	NULL
control	NULL
untreated	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

To	NULL
test	NULL
whether	NULL
the	NULL
H,0	NULL
,	NULL
-promoted	NULL
increase	NULL
in	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT3	NULL
was	NULL
accompanied	NULL
by	NULL
its	NULL
translocation	NULL
from	NULL
the	NULL
cytosol	NULL
to	NULL
the	NULL
nucleus	NULL
,	NULL
PBL	NULL
cells	NULL
treated	NULL
with	NULL
H	NULL
;	NULL
0	NULL
,	NULL
for	NULL
different	NULL
times	NULL
were	NULL
lysed	NULL
,	NULL
and	NULL
the	NULL
cytoplasmic	NULL
and	NULL
nuclear	NULL
fractions	NULL
were	NULL
subject	NULL
to	NULL
immunoblotting	NULL
analysis	NULL
using	NULL
anti-STAT3	NULL
antibodies	NULL
.	NULL

As	NULL
illustrated	NULL
in	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
STAT3	NULL
was	NULL
clearly	NULL
detectable	NULL
in	NULL
the	NULL
nucleus	NULL
after	NULL
10	NULL
min	NULL
of	NULL
treatment	NULL
with	NULL
H	NULL
;	NULL
0z	NULL
,	NULL
whereas	NULL
in	NULL
the	NULL
cytosol	NULL
the	NULL
STAT3	NULL
signal	NULL
at	NULL
this	NULL
time	NULL
was	NULL
significantly	NULL
diminished	NULL
.	NULL

Nuclear	NULL
translocation	NULL
of	NULL
STAT3	NULL
appeared	NULL
to	NULL
be	NULL
completed	NULL
after	NULL
30	NULL
min	NULL
,	NULL
because	NULL
no	NULL
cytosolic	NULL
STAT3	NULL
was	NULL
detected	NULL
at	NULL
this	NULL
point	NULL
.	NULL

In	NULL
some	NULL
untreated	NULL
cell	NULL
preparations	NULL
,	NULL
a	NULL
certain	NULL
amount	NULL
of	NULL
STAT3	NULL
was	NULL
found	NULL
in	NULL
the	NULL
nuclei	NULL
,	NULL
attributable	NULL
to	NULL
basal	NULL
levels	NULL
of	NULL
activation	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
stimulus	NULL
.	NULL

The	NULL
effect	NULL
on	NULL
STAT3	NULL
nuclear	NULL
translocation	NULL
of	NULL
phytohemag-glutinin	NULL
(	NULL
PHA	NULL
)	NULL
,	NULL
a	NULL
well	NULL
known	NULL
promoter	NULL
of	NULL
lymphocyte	NULL
prolifer-ation	NULL
,	NULL
was	NULL
also	NULL
analyzed	NULL
alone	NULL
or	NULL
in	NULL
combination	NULL
with	NULL
H	NULL
;	NULL
O	NULL
,	NULL
As	NULL
shown	NULL
,	NULL
PHA	NULL
by	NULL
itself	NULL
was	NULL
able	NULL
to	NULL
slightly	NULL
induce	NULL
STAT3	NULL
nuclear	NULL
translocation	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
lane	NULL
8	NULL
)	NULL
.	NULL

This	NULL
effect	NULL
was	NULL
,	NULL
however	NULL
,	NULL
considerably	NULL
enhanced	NULL
when	NULL
PHA	NULL
acted	NULL
in	NULL
combination	NULL
with	NULL
H,0	NULL
,	NULL
,	NULL
conditions	NULL
under	NULL
which	NULL
a	NULL
synergistic	NULL
effect	NULL
was	NULL
found	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
it	NULL
has	NULL
been	NULL
documented	NULL
that	NULL
the	NULL
treatment	NULL
of	NULL
T	NULL
lymphocytes	NULL
with	NULL
interleukin-2	NULL
results	NULL
in	NULL
an	NULL
increase	NULL
of	NULL
STAT3	NULL
tyrosine	NULL
phosphorylation	NULL
,	NULL
although	NULL
no	NULL
such	NULL
effect	NULL
was	NULL
observed	NULL
to	NULL
occur	NULL
in	NULL
cells	NULL
treated	NULL
with	NULL
PHA	NULL
for	NULL
3	NULL
days	NULL
(	NULL
37	NULL
)	NULL
.	NULL

Present	NULL
results	NULL
suggest	NULL
that	NULL
PHA	NULL
enhances	NULL
the	NULL
transduction	NULL
of	NULL
signals	NULL
that	NULL
are	NULL
required	NULL
for	NULL
optimal	NULL
H	NULL
;	NULL
O	NULL
,	NULL
effect	NULL
.	NULL

Hydrogen	NULL
Peroxide	NULL
and	NULL
Vanadate	NULL
Act	NULL
Synergistically	NULL
to	NULL
Induce	NULL
Nuclear	NULL
Translocation	NULL
of	NULL
STAT3-It	NULL
has	NULL
been	NULL
previously	NULL
proposed	NULL
that	NULL
the	NULL
combination	NULL
of	NULL
H	NULL
,	NULL
O	NULL
,	NULL
and	NULL
orthovanadate	NULL
potently	NULL
inhibits	NULL
PTPase	NULL
activity	NULL
(	NULL
25	NULL
,	NULL
26	NULL
)	NULL
and/or	NULL
synergistically	NULL
stimulates	NULL
insulin-dependent	NULL
PTK	NULL
activity	NULL
(	NULL
38	NULL
)	NULL
in	NULL
T	NULL
lymphocytes	NULL
.	NULL

Also	NULL
,	NULL
the	NULL
mixture	NULL
of	NULL
H	NULL
,	NULL
O	NULL
,	NULL
and	NULL
sodium	NULL
orthovanadate	NULL
promotes	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
phospholipase	NULL
Cy1	NULL
and	NULL
activates	NULL
p56	NULL
``	NULL
and	NULL
p59	NULL
tyrosine	NULL
kinases	NULL
(	NULL
23	NULL
)	NULL
.	NULL

These	NULL
facts	NULL
have	NULL
been	NULL
explained	NULL
in	NULL
the	NULL
light	NULL
of	NULL
inhibition	NULL
of	NULL
protein-tyrosine	NULL
phosphatase	NULL
(	NULL
s	NULL
)	NULL
by	NULL
pervanadate	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Further	NULL
experiments	NULL
were	NULL
therefore	NULL
used	NULL
to	NULL
analyze	NULL
whether	NULL
a	NULL
decrease	NULL
in	NULL
intracellular	NULL
PTPase	NULL
activity	NULL
could	NULL
be	NULL
implicated	NULL
in	NULL
the	NULL
H	NULL
;	NULL
O	NULL
,	NULL
-induced	NULL
STAT3	NULL
nuclear	NULL
translocation	NULL
effect	NULL
.	NULL

Toward	NULL
this	NULL
end	NULL
,	NULL
human	NULL
PBL	NULL
were	NULL
treated	NULL
with	NULL
orthovanadate	NULL
,	NULL
alone	NULL
or	NULL
in	NULL
combination	NULL
with	NULL
H	NULL
;	NULL
O	NULL
;	NULL
,	NULL
and	NULL
the	NULL
nuclear	NULL
levels	NULL
of	NULL
STAT3	NULL
were	NULL
Oxidative	NULL
Stress	NULL
Activates	NULL
Lymphocyte	NULL
STAT3	NULL
A	NULL
BLOT	NULL
:	NULL
STAT3	NULL
H,0,2mM	NULL
0	NULL
2	NULL
10	NULL
30	NULL
0	NULL
2	NULL
10	NULL
30	NULL
min	NULL
220	NULL
9	NULL
?	NULL

~	NULL
lan	NULL
me	NULL
ae	NULL
|	NULL
|	NULL
aa	NULL
e	NULL
mee	NULL
me	NULL
||	NULL
a-	NULL
ST	NULL
AT	NULL
3	NULL
67-43	NULL
wi	NULL
me	NULL
sus	NULL
|1	NULL
2	NULL
3	NULL
4	NULL
|5	NULL
6	NULL
7	NULL
8|	NULL
CYTOSOL	NULL
NUCLEAR	NULL
B	NULL
BLOT	NULL
:	NULL
STAT3	NULL
PHA	NULL
lOpghal	NULL
O0	NULL
6	NULL
16	NULL
24	NULL
0	NULL
6	NULL
16	NULL
24	NULL
h	NULL
220	NULL
2	NULL
-	NULL
vm	NULL
tee	NULL
ts	NULL
<	NULL
-STAT3	NULL
51—	NULL
we	NULL
ame	NULL
we	NULL
os	NULL
44	NULL
~	NULL
em	NULL
CYTOSOL	NULL
_	NULL
NUCLEAR	NULL
c	NULL
BLOT	NULL
:	NULL
STAT3	NULL
PHA	NULL
PHA	NULL
H	NULL
;	NULL
0	NULL
,	NULL
.	NULL

+	NULL
LCA	NULL
.	NULL

+	NULL
COA	NULL
220	NULL
97	NULL
-	NULL
--	NULL
4-STAT3	NULL
67-a34	NULL
1	NULL
2	NULL
3	NULL
4	NULL
[	NULL
5	NULL
6	NULL
1	NULL
8	NULL
|	NULL
CYTOSOL	NULL
_	NULL
NUCLEAR	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

H	NULL
,	NULL
O	NULL
,	NULL
and	NULL
PHA	NULL
induce	NULL
STAT3	NULL
translocation	NULL
from	NULL
the	NULL
cytosol	NULL
to	NULL
the	NULL
nucleus	NULL
in	NULL
human	NULL
lymphocytes	NULL
.	NULL

PBL	NULL
were	NULL
treated	NULL
with	NULL
2	NULL
mM	NULL
H	NULL
,	NULL
O	NULL
,	NULL
(	NULL
A	NULL
)	NULL
or	NULL
10	NULL
ug/ml	NULL
PHA	NULL
(	NULL
B	NULL
)	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
under	NULL
culture	NULL
conditions	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
lysed	NULL
in	NULL
buffer	NULL
A	NULL
,	NULL
and	NULL
the	NULL
cytoplasmic	NULL
and	NULL
nuclear	NULL
fractions	NULL
were	NULL
obtained	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

The	NULL
proteins	NULL
were	NULL
resolved	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
subject	NULL
to	NULL
immunoblotting	NULL
analysis	NULL
with	NULL
anti-STAT3	NULL
antibodies	NULL
.	NULL

C	NULL
,	NULL
PBL	NULL
were	NULL
treated	NULL
or	NULL
not	NULL
with	NULL
10	NULL
ug/ml	NULL
PHA	NULL
for	NULL
24	NULL
h	NULL
and	NULL
then	NULL
were	NULL
treated	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
2	NULL
mM	NULL
H	NULL
,	NULL
O	NULL
,	NULL
for	NULL
15	NULL
min	NULL
,	NULL
as	NULL
indicated	NULL
by	NULL
the	NULL
minus	NULL
and	NULL
plus	NULL
symbols	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
lysed	NULL
,	NULL
and	NULL
cytoplasmic	NULL
and	NULL
nuclear	NULL
fractions	NULL
were	NULL
analyzed	NULL
by	NULL
immunoblotting	NULL
with	NULL
anti-STAT3	NULL
antibodies	NULL
.	NULL

The	NULL
sizes	NULL
of	NULL
molecular	NULL
mass	NULL
markers	NULL
,	NULL
expressed	NULL
in	NULL
kDa	NULL
,	NULL
are	NULL
indicated	NULL
at	NULL
the	NULL
Zef	NULL
?	NULL

of	NULL
the	NULL
three	NULL
panels	NULL
.	NULL

Arrows	NULL
indicate	NULL
the	NULL
position	NULL
of	NULL
migration	NULL
of	NULL
STAT3	NULL
.	NULL

analyzed	NULL
.	NULL

Vanadate	NULL
alone	NULL
at	NULL
100	NULL
uM	NULL
(	NULL
the	NULL
maximal	NULL
dose	NULL
tested	NULL
)	NULL
promoted	NULL
a	NULL
slight	NULL
accumulation	NULL
of	NULL
STAT3	NULL
in	NULL
the	NULL
nucleus	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
and	NULL
H	NULL
;	NULL
O	NULL
,	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
lanes	NULL
1-4	NULL
)	NULL
induced	NULL
this	NULL
STAT3	NULL
translocation	NULL
detectable	NULL
only	NULL
at	NULL
the	NULL
highest	NULL
tested	NULL
concentration	NULL
(	NULL
2	NULL
mm	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
combination	NULL
of	NULL
vanadate	NULL
and	NULL
H	NULL
;	NULL
0	NULL
,	NULL
markedly	NULL
stimulated	NULL
in	NULL
a	NULL
synergistic	NULL
fashion	NULL
the	NULL
nuclear	NULL
translocation	NULL
of	NULL
STAT3	NULL
,	NULL
enhancing	NULL
about	NULL
6-fold	NULL
the	NULL
effect	NULL
obtained	NULL
with	NULL
2	NULL
mm	NULL
H	NULL
,	NULL
O	NULL
,	NULL
alone	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
at	NULL
100	NULL
um	NULL
vanadate	NULL
combined	NULL
with	NULL
a	NULL
low	NULL
dose	NULL
of	NULL
H	NULL
,	NULL
O	NULL
,	NULL
a	NULL
nuclear	NULL
translocation	NULL
of	NULL
STAT3	NULL
took	NULL
place	NULL
(	NULL
Zane	NULL
6	NULL
)	NULL
,	NULL
whereas	NULL
at	NULL
higher	NULL
concentrations	NULL
of	NULL
H	NULL
;	NULL
O	NULL
;	NULL
an	NULL
intense	NULL
nuclear	NULL
STAT3	NULL
signal	NULL
was	NULL
observed	NULL
(	NULL
Zanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
.	NULL

Effects	NULL
of	NULL
Phenylarsine	NULL
Oxide	NULL
,	NULL
Diamide	NULL
,	NULL
and	NULL
Genistein	NULL
on	NULL
H,0g-induced	NULL
Nuclear	NULL
Translocation	NULL
of	NULL
STAT3-Because	NULL
the	NULL
above	NULL
effects	NULL
of	NULL
pervanadate	NULL
could	NULL
be	NULL
due	NULL
to	NULL
the	NULL
inhibition	NULL
of	NULL
intracellular	NULL
tyrosine	NULL
phosphatase	NULL
(	NULL
s	NULL
)	NULL
,	NULL
experiments	NULL
were	NULL
attempted	NULL
to	NULL
analyze	NULL
whether	NULL
other	NULL
reagents	NULL
known	NULL
to	NULL
alter	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
status	NULL
of	NULL
proteins	NULL
could	NULL
influence	NULL
the	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
Oxidative	NULL
Stress	NULL
Activates	NULL
Lymphocyte	NULL
STAT3	NULL
A	NULL
Na	NULL
;	NULL
¥O	NULL
,	NULL
(	NULL
uM	NULL
)	NULL
0	NULL
100	NULL
(	NULL
mM	NULL
)	NULL
O0	NULL
O01	NULL
0.5	NULL
2	NULL
0	NULL
O01	NULL
0.5	NULL
2	NULL
104	NULL
$	NULL
2	NULL
-	NULL
i	NULL
%	NULL
48.3	NULL
33.4	NULL
10	NULL
2	NULL
3	NULL
40	NULL
50	NULL
60	NULL
108	NULL
BLOT	NULL
:	NULL
STAT3	NULL
so-	NULL
en	NULL
eath	NULL
_	NULL
a-	NULL
STAT3	NULL
17583	NULL
B	NULL
160	NULL
-e-	NULL
Nore	NULL
140	NULL
|	NULL
-	NULL
|-a-	NULL
(	NULL
100	NULL
pip	NULL
12	NULL
4	NULL
100	NULL
Densitometric	NULL
Arbitrary	NULL
Units	NULL
&	NULL
1	NULL
&	NULL
a	NULL
4	NULL
i	NULL
4	NULL
aA	NULL
-	NULL
/	NULL
o	NULL
U	NULL
t	NULL
¥	NULL
U	NULL
T	NULL
0.0	NULL
0.5	NULL
10	NULL
15	NULL
2D	NULL
[	NULL
H202	NULL
)	NULL
(	NULL
nM	NULL
)	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Orthovanadate	NULL
and	NULL
H	NULL
,	NULL
O	NULL
,	NULL
cooperatively	NULL
induce	NULL
STAT3	NULL
nuclear	NULL
translocation	NULL
.	NULL

A	NULL
,	NULL
PBL	NULL
were	NULL
treated	NULL
with	NULL
several	NULL
doses	NULL
of	NULL
H	NULL
,	NULL
O	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
100	NULL
uM	NULL
sodium	NULL
orthovanadate	NULL
for	NULL
15	NULL
min	NULL
at	NULL
87	NULL
°C	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
lysed	NULL
in	NULL
buffer	NULL
A	NULL
,	NULL
and	NULL
nuclear	NULL
fractions	NULL
obtained	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
``	NULL
were	NULL
resolved	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
analyzed	NULL
by	NULL
immunoblotting	NULL
with	NULL
anti-STAT3	NULL
antibodies	NULL
.	NULL

The	NULL
arrow	NULL
indicates	NULL
the	NULL
STAT3	NULL
band	NULL
.	NULL

The	NULL
sizes	NULL
of	NULL
molecular	NULL
mass	NULL
markers	NULL
,	NULL
expressed	NULL
in	NULL
kDa	NULL
,	NULL
are	NULL
indicated	NULL
at	NULL
the	NULL
left	NULL
of	NULL
panel	NULL
A	NULL
.	NULL

B	NULL
,	NULL
STATS	NULL
nuclear	NULL
levels	NULL
obtained	NULL
from	NULL
densitometric	NULL
analysis	NULL
of	NULL
panel	NULL
!	NULL

A	NULL
are	NULL
plotted	NULL
versus	NULL
the	NULL
concentration	NULL
of	NULL
H,0	NULL
,	NULL
.	NULL

A	NULL
PAO	NULL
(	NULL
uM	NULL
)	NULL
BLOT	NULL
:	NULL
STAT	NULL
3	NULL
Le	NULL
i	NULL
.	NULL

|0.1	NULL
1	NULL
10	NULL
50	NULL
ml	NULL
220	NULL
mse	NULL
eac	NULL
«	NULL
-srar	NULL
:	NULL
67	NULL
_-43	NULL
__	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
B	NULL
BLOT	NULL
:	NULL
STAT	NULL
3	NULL
H,0	NULL
,	NULL
oe	NULL
+	NULL
Diamide	NULL
mos	NULL
®	NULL
#	NULL
®	NULL
-	NULL
m	NULL
#	NULL
=	NULL
PAO	NULL
«	NULL
o	NULL
&	NULL
®	NULL
w	NULL
g	NULL
4	NULL
y	NULL
o	NULL
Genistein	NULL
|	NULL
L	NULL
L	NULL
L	NULL
.L	NULL
.	NULL

L	NULL
y	NULL
40	NULL
4	NULL
04	NULL
104	NULL
81	NULL
-	NULL
sum	NULL
|	NULL
ume	NULL
mas	NULL
sume	NULL
4-STAT3	NULL
48	NULL
35	NULL
10	NULL
20	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

PAO	NULL
induces	NULL
nuclear	NULL
translocation	NULL
of	NULL
STAT3	NULL
.	NULL

A	NULL
,	NULL
PBL	NULL
were	NULL
left	NULL
untreated	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
were	NULL
treated	NULL
for	NULL
15	NULL
min	NULL
with	NULL
2	NULL
mM	NULL
H	NULL
,	NULL
O	NULL
,	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
with	NULL
1	NULL
pl	NULL
of	NULL
Me	NULL
,	NULL
SO	NULL
(	NULL
Zane	NULL
3	NULL
)	NULL
,	NULL
or	NULL
with	NULL
the	NULL
indicated	NULL
doses	NULL
of	NULL
PAQ	NULL
(	NULL
lanes	NULL
4-8	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
lysed	NULL
in	NULL
buffer	NULL
A	NULL
,	NULL
and	NULL
nuclear	NULL
fractions	NULL
were	NULL
resolved	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
analyzed	NULL
by	NULL
immunoblotting	NULL
with	NULL
anti-STAT3	NULL
antibodies	NULL
.	NULL

B	NULL
,	NULL
PBL	NULL
were	NULL
subjected	NULL
to	NULL
the	NULL
indicated	NULL
treat-ments	NULL
.	NULL

PBL	NULL
were	NULL
left	NULL
untreated	NULL
(	NULL
Zanes	NULL
1-5	NULL
)	NULL
or	NULL
treated	NULL
(	NULL
lanes	NULL
6-9	NULL
)	NULL
with	NULL
genistein	NULL
(	NULL
100	NULL
uM	NULL
)	NULL
for	NULL
30	NULL
min	NULL
,	NULL
followed	NULL
by	NULL
2	NULL
mM	NULL
H	NULL
,	NULL
O	NULL
,	NULL
(	NULL
Zanes	NULL
2	NULL
and	NULL
6	NULL
)	NULL
,	NULL
1	NULL
mM	NULL
diamide	NULL
(	NULL
Zanes	NULL
3	NULL
and	NULL
7	NULL
)	NULL
,	NULL
or	NULL
100	NULL
uM	NULL
PAO	NULL
(	NULL
Zanes	NULL
4	NULL
and	NULL
8	NULL
)	NULL
for	NULL
15	NULL
min	NULL
.	NULL

In	NULL
lanes	NULL
5	NULL
and	NULL
9	NULL
,	NULL
H	NULL
,	NULL
O	NULL
,	NULL
and	NULL
PAO	NULL
were	NULL
added	NULL
together	NULL
at	NULL
the	NULL
same	NULL
time	NULL
.	NULL

Nuclear	NULL
fractions	NULL
were	NULL
analyzed	NULL
by	NULL
immunoblotting	NULL
with	NULL
anti-STAT3	NULL
antibodies	NULL
.	NULL

The	NULL
arrows	NULL
indicate	NULL
the	NULL
STAT3	NULL
band	NULL
,	NULL
and	NULL
the	NULL
sizes	NULL
of	NULL
molecular	NULL
mass	NULL
markers	NULL
,	NULL
expressed	NULL
in	NULL
kDa	NULL
,	NULL
are	NULL
indicated	NULL
at	NULL
the	NULL
left	NULL
of	NULL
both	NULL
panels	NULL
.	NULL

nuclear	NULL
translocation	NULL
of	NULL
STAT3	NULL
.	NULL

Because	NULL
the	NULL
effect	NULL
of	NULL
PAO	NULL
as	NULL
a	NULL
PTPase	NULL
inhibitor	NULL
in	NULL
T	NULL
lymphocytes	NULL
is	NULL
well	NULL
known	NULL
(	NULL
89	NULL
)	NULL
,	NULL
we	NULL
decided	NULL
to	NULL
test	NULL
its	NULL
effect	NULL
on	NULL
STAT3	NULL
nuclear	NULL
translocation	NULL
in	NULL
BLOT	NULL
:	NULL
-	NULL
«	NULL
STAT3	NULL
«	NULL
STAT	NULL
oSTATSB	NULL
220	NULL
-	NULL
s	NULL
lata	NULL
ars	NULL
97	NULL
ws	NULL
a	NULL
<	NULL
-	NULL
STATs	NULL
67	NULL
43	NULL
30	NULL
e	NULL
3	NULL
-	NULL
4	NULL
50	NULL
6	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

H	NULL
,	NULL
O	NULL
,	NULL
induces	NULL
nuclear	NULL
translocation	NULL
of	NULL
STAT3	NULL
but	NULL
not	NULL
of	NULL
STAT1	NULL
or	NULL
STAT5B	NULL
.	NULL

PBL	NULL
were	NULL
left	NULL
untreated	NULL
(	NULL
-	NULL
)	NULL
or	NULL
were	NULL
treated	NULL
(	NULL
+	NULL
)	NULL
with	NULL
2	NULL
mM	NULL
H,0	NULL
,	NULL
for	NULL
15	NULL
min	NULL
,	NULL
and	NULL
nuclear	NULL
fraction	NULL
samples	NULL
were	NULL
resolved	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
analyzed	NULL
by	NULL
immunoblotting	NULL
with	NULL
anti-STAT3	NULL
,	NULL
anti-STAT1	NULL
,	NULL
or	NULL
anti-STAT5B	NULL
antibodies	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

human	NULL
PBL	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
PAO	NULL
induced	NULL
a	NULL
dose-depend-ent	NULL
enhancement	NULL
of	NULL
STAT3	NULL
nuclear	NULL
translocation	NULL
,	NULL
as	NULL
monitored	NULL
in	NULL
nuclear	NULL
fractions	NULL
from	NULL
cells	NULL
treated	NULL
with	NULL
different	NULL
concentrations	NULL
of	NULL
PAO	NULL
,	NULL
upon	NULL
immunoblotting	NULL
analysis	NULL
with	NULL
anti-STAT3	NULL
antibodies	NULL
.	NULL

It	NULL
could	NULL
also	NULL
be	NULL
observed	NULL
that	NULL
the	NULL
nuclear	NULL
levels	NULL
of	NULL
this	NULL
factor	NULL
reached	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
2	NULL
mx	NULL
H	NULL
,	NULL
O	NULL
,	NULL
could	NULL
be	NULL
mimicked	NULL
by	NULL
50	NULL
um	NULL
PAO	NULL
.	NULL

Furthermore	NULL
,	NULL
PAO	NULL
and	NULL
were	NULL
found	NULL
to	NULL
act	NULL
in	NULL
a	NULL
synergistic	NULL
fashion	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
compare	NULL
lanes	NULL
2	NULL
and	NULL
4	NULL
with	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
which	NULL
suggests	NULL
that	NULL
both	NULL
molecules	NULL
could	NULL
be	NULL
cooperatively	NULL
acting	NULL
as	NULL
inhibitors	NULL
of	NULL
intracellular	NULL
tyrosine	NULL
phosphatases	NULL
.	NULL

Diamide	NULL
,	NULL
a	NULL
compound	NULL
with	NULL
oxidative	NULL
properties	NULL
(	NULL
12	NULL
,	NULL
13	NULL
)	NULL
,	NULL
was	NULL
also	NULL
shown	NULL
to	NULL
stimulate	NULL
the	NULL
nuclear	NULL
translocation	NULL
of	NULL
STAT3	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

This	NULL
drug	NULL
was	NULL
reported	NULL
to	NULL
induce	NULL
a	NULL
marked	NULL
enhancement	NULL
of	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
status	NULL
of	NULL
several	NULL
cellular	NULL
proteins	NULL
(	NULL
13	NULL
,	NULL
40	NULL
)	NULL
,	NULL
possibly	NULL
mediated	NULL
by	NULL
inhibition	NULL
of	NULL
tyrosine	NULL
phosphatase	NULL
(	NULL
s	NULL
)	NULL
(	NULL
13	NULL
,	NULL
37	NULL
)	NULL
.	NULL

In	NULL
an	NULL
opposite	NULL
fashion	NULL
,	NULL
genistein	NULL
,	NULL
an	NULL
inhibitor	NULL
of	NULL
protein-tyrosine	NULL
kinases	NULL
,	NULL
produced	NULL
a	NULL
partial	NULL
inhibition	NULL
of	NULL
the	NULL
STAT3	NULL
nuclear	NULL
translocation	NULL
elicited	NULL
by	NULL
H	NULL
,	NULL
O	NULL
,	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
or	NULL
diamide	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
.	NULL

However	NULL
,	NULL
genistein	NULL
was	NULL
unable	NULL
to	NULL
counteract	NULL
the	NULL
stimulating	NULL
action	NULL
of	NULL
PAO	NULL
(	NULL
lane	NULL
8	NULL
)	NULL
.	NULL

These	NULL
results	NULL
clearly	NULL
suggest	NULL
that	NULL
the	NULL
nuclear	NULL
levels	NULL
of	NULL
STAT3	NULL
are	NULL
balanced	NULL
by	NULL
the	NULL
opposite	NULL
actions	NULL
of	NULL
intracellular	NULL
PTKs	NULL
and	NULL
PTPases	NULL
.	NULL

Experiments	NULL
were	NULL
also	NULL
conducted	NULL
to	NULL
study	NULL
the	NULL
specificity	NULL
of	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
17584	NULL
H,0	NULL
,	NULL
=	NULL
=	NULL
4	NULL
+	NULL
l	NULL
1	NULL
>	NULL
10-Phe	NULL
E	NULL
C	NULL
w	NULL
=p	NULL
220	NULL
4	NULL
,	NULL
«	NULL
-	NULL
STAT3	NULL
67	NULL
30	NULL
1°	NULL
2	NULL
0	NULL
3	NULL
-	NULL
4	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

Pretreatment	NULL
with	NULL
FeSQO	NULL
,	NULL
/CuSO	NULL
,	NULL
or	NULL
1,10-phenantroline	NULL
modulates	NULL
STAT3	NULL
nuclear	NULL
translocation	NULL
induced	NULL
by	NULL
H	NULL
,	NULL
O	NULL
,	NULL
.	NULL

PBL	NULL
were	NULL
left	NULL
untreated	NULL
(	NULL
Zane	NULL
1	NULL
)	NULL
,	NULL
treated	NULL
with	NULL
2	NULL
mM	NULL
H	NULL
,	NULL
O	NULL
,	NULL
(	NULL
Zane	NULL
2	NULL
)	NULL
for	NULL
15	NULL
min	NULL
,	NULL
or	NULL
pretreated	NULL
for	NULL
15	NULL
min	NULL
with	NULL
100	NULL
um	NULL
FeSO	NULL
,	NULL
/100	NULL
um	NULL
CuSO	NULL
,	NULL
(	NULL
Zane	NULL
3	NULL
)	NULL
or	NULL
20	NULL
uM	NULL
1,10-phenantroline	NULL
(	NULL
1	NULL
,	NULL
10-Phe	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
and	NULL
then	NULL
exposed	NULL
to	NULL
2	NULL
mM	NULL
H	NULL
,	NULL
O	NULL
,	NULL
for	NULL
a	NULL
further	NULL
15	NULL
min	NULL
.	NULL

Nuclear	NULL
fractions	NULL
were	NULL
resolved	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
analyzed	NULL
by	NULL
immunoblotting	NULL
with	NULL
anti-STAT3	NULL
antibodies	NULL
.	NULL

oxidant-induced	NULL
STAT	NULL
nuclear	NULL
translocation	NULL
.	NULL

Immunoblotting	NULL
analyses	NULL
of	NULL
PBL	NULL
nuclear	NULL
extracts	NULL
reveals	NULL
that	NULL
H	NULL
,	NULL
O	NULL
,	NULL
treatment	NULL
lightly	NULL
induced	NULL
the	NULL
nuclear	NULL
translocation	NULL
of	NULL
STAT1	NULL
and	NULL
STAT5B	NULL
,	NULL
although	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
than	NULL
that	NULL
observed	NULL
for	NULL
STAT3	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

The	NULL
distinct	NULL
behavior	NULL
displayed	NULL
by	NULL
these	NULL
STAT	NULL
proteins	NULL
upon	NULL
cell	NULL
challenge	NULL
with	NULL
H	NULL
,	NULL
O	NULL
,	NULL
agrees	NULL
with	NULL
recent	NULL
observations	NULL
regarding	NULL
their	NULL
activation	NULL
by	NULL
different	NULL
cytokines	NULL
and	NULL
growth	NULL
factors	NULL
(	NULL
41	NULL
)	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
G-CSF	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT1	NULL
,	NULL
STAT3	NULL
,	NULL
and	NULL
STAT5B	NULL
;	NULL
however	NULL
,	NULL
STAT5B	NULL
can	NULL
be	NULL
activated	NULL
by	NULL
mutant	NULL
receptors	NULL
that	NULL
lack	NULL
tyrosine	NULL
residues	NULL
(	NULL
41	NULL
,	NULL
42	NULL
)	NULL
.	NULL

Moreover	NULL
efficient	NULL
STAT3	NULL
activation	NULL
requires	NULL
additional	NULL
receptor	NULL
sequences	NULL
that	NULL
include	NULL
Tyr	NULL
'	NULL
``	NULL
*	NULL
(	NULL
42	NULL
)	NULL
.	NULL

Effect	NULL
of	NULL
Fe	NULL
``	NULL
?	NULL

Cu	NULL
``	NULL
Ions	NULL
on	NULL
STAT3	NULL
Nuclear	NULL
Translocation-After	NULL
passive	NULL
diffusion	NULL
through	NULL
the	NULL
plasma	NULL
membrane	NULL
,	NULL
H	NULL
,	NULL
O	NULL
,	NULL
can	NULL
be	NULL
converted	NULL
into	NULL
other	NULL
active	NULL
oxygen	NULL
species	NULL
,	NULL
such	NULL
as	NULL
O	NULL
;	NULL
and	NULL
'OH	NULL
(	NULL
23	NULL
)	NULL
.	NULL

The	NULL
most	NULL
likely	NULL
mode	NULL
of	NULL
intracellular	NULL
'OH	NULL
radical	NULL
production	NULL
is	NULL
via	NULL
Fenton	NULL
chemistry	NULL
,	NULL
which	NULL
involves	NULL
the	NULL
reduction	NULL
of	NULL
H	NULL
,	NULL
O	NULL
,	NULL
by	NULL
ferrous	NULL
ions	NULL
according	NULL
to	NULL
the	NULL
reaction	NULL
:	NULL
H	NULL
,	NULL
O	NULL
,	NULL
+	NULL
Fe**	NULL
-	NULL
``	NULL
'OH	NULL
+	NULL
OH~	NULL
+	NULL
Fe®*	NULL
(	NULL
8	NULL
)	NULL
.	NULL

Also	NULL
,	NULL
cuprous	NULL
ions	NULL
are	NULL
elemental	NULL
producers	NULL
of	NULL
'OH	NULL
radicals	NULL
via	NULL
Fenton	NULL
reactions	NULL
(	NULL
9	NULL
)	NULL
.	NULL

We	NULL
have	NULL
analyzed	NULL
whether	NULL
the	NULL
chemical	NULL
species	NULL
generated	NULL
from	NULL
H,0	NULL
,	NULL
through	NULL
Fenton	NULL
reactions	NULL
could	NULL
affect	NULL
STAT3	NULL
nuclear	NULL
translocation	NULL
.	NULL

Fig	NULL
.	NULL

6	NULL
illustrates	NULL
that	NULL
the	NULL
prior	NULL
addition	NULL
of	NULL
Fe®*	NULL
and	NULL
Cu®*	NULL
ions	NULL
notably	NULL
enhanced	NULL
the	NULL
H,0	NULL
,	NULL
-induced	NULL
nuclear	NULL
translocation	NULL
of	NULL
STAT3	NULL
(	NULL
Zane	NULL
3	NULL
)	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
the	NULL
pretreatment	NULL
of	NULL
cells	NULL
with	NULL
1,10-phenantroline	NULL
,	NULL
a	NULL
chelator	NULL
of	NULL
copper	NULL
and	NULL
iron	NULL
ions	NULL
resulted	NULL
in	NULL
cancellation	NULL
of	NULL
the	NULL
STAT3	NULL
nuclear	NULL
accumulation	NULL
induced	NULL
by	NULL
H0	NULL
,	NULL
(	NULL
Zane	NULL
4	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
intracellular	NULL
reduction	NULL
of	NULL
H	NULL
;	NULL
0	NULL
;	NULL
to	NULL
yield	NULL
more	NULL
reactive	NULL
oxygen	NULL
species	NULL
,	NULL
such	NULL
as	NULL
'OH	NULL
,	NULL
could	NULL
constitute	NULL
a	NULL
more	NULL
efficient	NULL
mechanism	NULL
for	NULL
the	NULL
positive	NULL
action	NULL
of	NULL
H	NULL
,	NULL
O	NULL
;	NULL
on	NULL
STAT3	NULL
.	NULL

Hydrogen	NULL
Peroxide	NULL
Enhances	NULL
STAT3	NULL
DNA	NULL
Binding	NULL
Activi-ty-The	NULL
enhancement	NULL
of	NULL
the	NULL
ability	NULL
of	NULL
nuclear	NULL
STAT	NULL
's	NULL
to	NULL
bind	NULL
to	NULL
specific	NULL
DNA	NULL
elements	NULL
in	NULL
PBL	NULL
cells	NULL
upon	NULL
cell	NULL
stimulation	NULL
by	NULL
oxidizing	NULL
agents	NULL
was	NULL
assessed	NULL
through	NULL
gel	NULL
mobility	NULL
shift	NULL
assays	NULL
Oxidative	NULL
Stress	NULL
Activates	NULL
Lymphocyte	NULL
STAT3	NULL
using	NULL
a	NULL
double-stranded	NULL
oligonucleotide	NULL
probe	NULL
containing	NULL
a	NULL
high	NULL
affinity	NULL
target	NULL
sequence	NULL
for	NULL
STAT	NULL
factors	NULL
.	NULL

This	NULL
binding	NULL
sequence	NULL
,	NULL
named	NULL
m67	NULL
,	NULL
was	NULL
derived	NULL
from	NULL
the	NULL
sis-inducible	NULL
element	NULL
(	NULL
SIE	NULL
)	NULL
of	NULL
the	NULL
human	NULL
c-fos	NULL
promoter	NULL
(	NULL
43	NULL
,	NULL
44	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
thus	NULL
prepared	NULL
from	NULL
PBL	NULL
challenged	NULL
with	NULL
orthovanadate	NULL
,	NULL
H,0	NULL
,	NULL
,	NULL
or	NULL
both	NULL
and	NULL
incubated	NULL
with	NULL
the	NULL
digoxigenin-labeled	NULL
SIE	NULL
m67	NULL
oligonucleotide	NULL
probe	NULL
.	NULL

Fig	NULL
.	NULL

7A	NULL
illustrates	NULL
that	NULL
H	NULL
,	NULL
O	NULL
,	NULL
induced	NULL
a	NULL
rapid	NULL
assembly	NULL
of	NULL
complexes	NULL
able	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
SIE	NULL
m67	NULL
probe	NULL
within	NULL
PBL	NULL
nuclei	NULL
(	NULL
Zane	NULL
3	NULL
)	NULL
.	NULL

The	NULL
same	NULL
effect	NULL
was	NULL
observed	NULL
upon	NULL
vanadate	NULL
treatment	NULL
(	NULL
Zane	NULL
2	NULL
)	NULL
,	NULL
and	NULL
a	NULL
cooperative	NULL
effect	NULL
was	NULL
found	NULL
to	NULL
take	NULL
place	NULL
between	NULL
vanadate	NULL
and	NULL
H	NULL
,	NULL
O	NULL
,	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

As	NULL
a	NULL
positive	NULL
control	NULL
,	NULL
we	NULL
also	NULL
analyzed	NULL
the	NULL
effect	NULL
of	NULL
interferon-a	NULL
(	NULL
18	NULL
)	NULL
,	NULL
with	NULL
the	NULL
same	NULL
results	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

The	NULL
shifted	NULL
band	NULL
could	NULL
be	NULL
competed	NULL
by	NULL
an	NULL
excess	NULL
of	NULL
unlabeled	NULL
SIE	NULL
m67	NULL
oligonucleotide	NULL
;	NULL
thus	NULL
,	NULL
it	NULL
indicates	NULL
that	NULL
nuclear	NULL
factor	NULL
binding	NULL
was	NULL
specific	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

However	NULL
,	NULL
quite	NULL
in-triguingly	NULL
,	NULL
we	NULL
found	NULL
that	NULL
treatment	NULL
with	NULL
PAO	NULL
,	NULL
despite	NULL
this	NULL
compound	NULL
enhanced	NULL
STAT3	NULL
nuclear	NULL
translocation	NULL
,	NULL
cancelled	NULL
completely	NULL
nuclear	NULL
factor	NULL
binding	NULL
to	NULL
the	NULL
STAT	NULL
specific	NULL
sequence	NULL
,	NULL
even	NULL
below	NULL
basal	NULL
levels	NULL
of	NULL
binding	NULL
seen	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
H	NULL
,	NULL
O	NULL
,	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

We	NULL
can	NULL
not	NULL
offer	NULL
any	NULL
explanation	NULL
for	NULL
this	NULL
fact	NULL
,	NULL
although	NULL
it	NULL
could	NULL
be	NULL
related	NULL
to	NULL
the	NULL
hyperphosphory-lation	NULL
of	NULL
proteins	NULL
(	NULL
e.g	NULL
.	NULL

STAT3	NULL
)	NULL
found	NULL
to	NULL
occur	NULL
after	NULL
PAO	NULL
treatment	NULL
(	NULL
38	NULL
,	NULL
45	NULL
,	NULL
46	NULL
)	NULL
.	NULL

Fig	NULL
.	NULL

7B	NULL
illustrates	NULL
that	NULL
the	NULL
presence	NULL
of	NULL
Fe	NULL
``	NULL
*/Cu	NULL
``	NULL
*	NULL
in	NULL
combination	NULL
with	NULL
H	NULL
,	NULL
O	NULL
,	NULL
greatly	NULL
enhanced	NULL
the	NULL
capacity	NULL
of	NULL
nuclear	NULL
factors	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
SIE	NULL
m67	NULL
oligonucleotide	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
and	NULL
that	NULL
the	NULL
addition	NULL
of	NULL
1,10-phenantroline	NULL
reduced	NULL
the	NULL
H,0	NULL
,	NULL
-induced	NULL
nuclear	NULL
factor	NULL
binding	NULL
.	NULL

These	NULL
results	NULL
show	NULL
a	NULL
clear	NULL
correlation	NULL
with	NULL
the	NULL
observations	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
regarding	NULL
the	NULL
nuclear	NULL
translocation	NULL
of	NULL
STAT3	NULL
.	NULL

DISCUSSION	NULL
The	NULL
intracellular	NULL
processes	NULL
that	NULL
become	NULL
triggered	NULL
upon	NULL
oxidative	NULL
stress	NULL
constitute	NULL
nowadays	NULL
a	NULL
focus	NULL
of	NULL
extensive	NULL
research	NULL
.	NULL

Very	NULL
recently	NULL
,	NULL
we	NULL
have	NULL
described	NULL
that	NULL
H	NULL
,	NULL
O	NULL
;	NULL
and	NULL
other	NULL
peroxides	NULL
are	NULL
able	NULL
to	NULL
inhibit	NULL
calcineurin	NULL
activity	NULL
and	NULL
to	NULL
inactivate	NULL
nuclear	NULL
factor	NULL
«	NULL
B	NULL
DNA	NULL
binding	NULL
in	NULL
human	NULL
neutrophils	NULL
(	NULL
36	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
Schreck	NULL
et	NULL
al	NULL
.	NULL

(	NULL
2	NULL
)	NULL
have	NULL
provided	NULL
evidence	NULL
that	NULL
peroxides	NULL
activate	NULL
nuclear	NULL
factor	NULL
kB	NULL
in	NULL
lymphocytes	NULL
through	NULL
an	NULL
undetermined	NULL
mechanism	NULL
involving	NULL
the	NULL
synthesis	NULL
of	NULL
ROL	NULL
.	NULL

Also	NULL
,	NULL
H,0	NULL
,	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
the	NULL
positive	NULL
modulation	NULL
of	NULL
the	NULL
activity	NULL
of	NULL
a	NULL
number	NULL
of	NULL
PTKs	NULL
whose	NULL
function	NULL
is	NULL
critical	NULL
for	NULL
lymphocyte	NULL
activation	NULL
(	NULL
11	NULL
,	NULL
47	NULL
)	NULL
.	NULL

An	NULL
involvement	NULL
of	NULL
STAT	NULL
factors	NULL
in	NULL
mediating	NULL
leukocyte	NULL
activation	NULL
elicited	NULL
by	NULL
interleukin-2	NULL
has	NULL
been	NULL
recently	NULL
discovered	NULL
(	NULL
83	NULL
,	NULL
37	NULL
,	NULL
48	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
potential	NULL
role	NULL
of	NULL
STAT	NULL
factors	NULL
as	NULL
mediators	NULL
of	NULL
peroxide-triggered	NULL
lymphocyte	NULL
activation	NULL
,	NULL
by	NULL
acting	NULL
as	NULL
target	NULL
molecules	NULL
of	NULL
oxidative	NULL
processes	NULL
,	NULL
has	NULL
not	NULL
been	NULL
previously	NULL
explored	NULL
.	NULL

In	NULL
this	NULL
paper	NULL
,	NULL
we	NULL
provide	NULL
the	NULL
first	NULL
evidence	NULL
that	NULL
H	NULL
,	NULL
O	NULL
,	NULL
promotes	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT3	NULL
in	NULL
peripheral	NULL
blood	NULL
human	NULL
lymphocytes	NULL
,	NULL
which	NULL
is	NULL
followed	NULL
by	NULL
its	NULL
translocation	NULL
to	NULL
the	NULL
nucleus	NULL
and	NULL
binding	NULL
to	NULL
a	NULL
specific	NULL
DNA	NULL
element	NULL
.	NULL

It	NULL
is	NULL
well	NULL
established	NULL
that	NULL
the	NULL
activation	NULL
of	NULL
STAT	NULL
factors	NULL
requires	NULL
their	NULL
phosphorylation	NULL
on	NULL
tyrosine	NULL
residue	NULL
(	NULL
s	NULL
)	NULL
(	NULL
34	NULL
)	NULL
.	NULL

To	NULL
explain	NULL
the	NULL
mechanism	NULL
whereby	NULL
they	NULL
become	NULL
activated	NULL
by	NULL
oxidants	NULL
,	NULL
two	NULL
possibilities	NULL
can	NULL
be	NULL
contemplated	NULL
.	NULL

First	NULL
,	NULL
the	NULL
alteration	NULL
of	NULL
their	NULL
redox	NULL
status	NULL
could	NULL
directly	NULL
alter	NULL
STAT	NULL
conforma-tion	NULL
,	NULL
in	NULL
such	NULL
a	NULL
way	NULL
that	NULL
their	NULL
interaction	NULL
with	NULL
cytosolic	NULL
proteins	NULL
responsible	NULL
for	NULL
nuclear	NULL
targeting	NULL
would	NULL
be	NULL
enabled	NULL
.	NULL

Because	NULL
the	NULL
structures	NULL
of	NULL
STAT3	NULL
and	NULL
especially	NULL
its	NULL
presumptive	NULL
redox	NULL
centers	NULL
are	NULL
not	NULL
completely	NULL
understood	NULL
,	NULL
this	NULL
hypothesis	NULL
requires	NULL
further	NULL
investigation	NULL
.	NULL

The	NULL
current	NULL
state	NULL
of	NULL
knowledge	NULL
thus	NULL
makes	NULL
more	NULL
likely	NULL
a	NULL
second	NULL
explanation	NULL
based	NULL
on	NULL
the	NULL
ability	NULL
of	NULL
oxidants	NULL
to	NULL
act	NULL
as	NULL
inhibitors	NULL
of	NULL
tyrosine	NULL
phosphatases	NULL
.	NULL

According	NULL
to	NULL
this	NULL
possibility	NULL
,	NULL
STAT3	NULL
nuclear	NULL
translocation	NULL
would	NULL
be	NULL
facilitated	NULL
or	NULL
promoted	NULL
by	NULL
its	NULL
increased	NULL
status	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
,	NULL
this	NULL
being	NULL
the	NULL
consequence	NULL
of	NULL
inhibition	NULL
by	NULL
of	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
Oxidative	NULL
Stress	NULL
Activates	NULL
Lymphocyte	NULL
STAT3	NULL
J	NULL
>	NULL
4,0	NULL
,	NULL
Ns	NULL
,	NULL
¥0/A,0	NULL
,	NULL
Na	NULL
,	NULL
VO	NULL
,	NULL
1,10-Phe	NULL
+	NULL
H	NULL
,	NULL
O	NULL
,	NULL
FelCu+	NULL
H	NULL
,	NULL
O	NULL
,	NULL
I	NULL
i	NULL
|	NULL
ow	NULL
coe	NULL
wis	NULL
maas	NULL
10	NULL
20	NULL
300	NULL
40	NULL
Fic	NULL
.	NULL

7	NULL
.	NULL

H	NULL
,	NULL
O	NULL
,	NULL
enhances	NULL
STAT3	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

A	NULL
,	NULL
PBL	NULL
were	NULL
left	NULL
untreated	NULL
(	NULL
Zane	NULL
1	NULL
)	NULL
or	NULL
were	NULL
treated	NULL
with	NULL
100	NULL
uM	NULL
Na	NULL
,	NULL
VO	NULL
,	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
2	NULL
mM	NULL
H,0	NULL
,	NULL
(	NULL
Zane	NULL
3	NULL
)	NULL
,	NULL
both	NULL
H	NULL
,	NULL
O	NULL
,	NULL
and	NULL
Na	NULL
,	NULL
VO	NULL
,	NULL
added	NULL
at	NULL
the	NULL
same	NULL
time	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
or	NULL
1000	NULL
units/ml	NULL
interferon-a	NULL
«	NULL
(	NULL
Zane	NULL
5	NULL
)	NULL
for	NULL
10	NULL
min	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
lysed	NULL
in	NULL
buffer	NULL
C	NULL
,	NULL
and	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

DNA	NULL
binding	NULL
to	NULL
the	NULL
digoxigenin-labeled	NULL
SIE	NULL
m67	NULL
oligonucleotide	NULL
probe	NULL
was	NULL
assessed	NULL
by	NULL
gel	NULL
mobility	NULL
shift	NULL
assays	NULL
.	NULL

The	NULL
retarded	NULL
band	NULL
is	NULL
indicated	NULL
by	NULL
an	NULL
arrow	NULL
.	NULL

Where	NULL
indicated	NULL
by	NULL
an	NULL
asterisk	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
binding	NULL
reactions	NULL
were	NULL
performed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
oligonucleotide	NULL
in	NULL
the	NULL
reaction	NULL
performed	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
H	NULL
,	NULL
O0	NULL
,	NULL
-treated	NULL
human	NULL
lymphocytes	NULL
.	NULL

B	NULL
,	NULL
PBL	NULL
were	NULL
left	NULL
untreated	NULL
(	NULL
Zane	NULL
1	NULL
)	NULL
or	NULL
treated	NULL
with	NULL
2	NULL
mM	NULL
H,0	NULL
,	NULL
,	NULL
alone	NULL
(	NULL
Zane	NULL
2	NULL
)	NULL
or	NULL
in	NULL
combination	NULL
with	NULL
100	NULL
um	NULL
FeSO	NULL
,	NULL
/100	NULL
um	NULL
CuSO	NULL
,	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
or	NULL
20	NULL
uM	NULL
1,10-phenantroline	NULL
(	NULL
1,10-Phe	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
for	NULL
15	NULL
min	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
used	NULL
for	NULL
gel	NULL
mobility	NULL
shift	NULL
assays	NULL
as	NULL
indicated	NULL
for	NULL
panel	NULL
A.	NULL
the	NULL
activity	NULL
of	NULL
intracellular	NULL
PTPases	NULL
(	NULL
25	NULL
,	NULL
39	NULL
)	NULL
.	NULL

In	NULL
this	NULL
context	NULL
,	NULL
exogenously	NULL
added	NULL
H	NULL
,	NULL
O	NULL
;	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
increase	NULL
protein-tyrosine	NULL
phosphorylation	NULL
in	NULL
several	NULL
cell	NULL
types	NULL
,	NULL
such	NULL
as	NULL
lung	NULL
epithelial	NULL
and	NULL
FAO	NULL
cells	NULL
(	NULL
49	NULL
,	NULL
50	NULL
)	NULL
.	NULL

Also	NULL
,	NULL
H	NULL
,	NULL
O	NULL
,	NULL
can	NULL
directly	NULL
inhibit	NULL
PTPase	NULL
activity	NULL
in	NULL
vitro	NULL
,	NULL
and	NULL
this	NULL
inhibition	NULL
can	NULL
be	NULL
completely	NULL
reversed	NULL
by	NULL
dithiothreitol	NULL
(	NULL
25	NULL
)	NULL
.	NULL

All	NULL
PTPases	NULL
are	NULL
known	NULL
to	NULL
contain	NULL
an	NULL
essential	NULL
sulfhydryl	NULL
group	NULL
at	NULL
their	NULL
active	NULL
site	NULL
,	NULL
which	NULL
is	NULL
susceptible	NULL
to	NULL
oxidation	NULL
because	NULL
of	NULL
its	NULL
unusually	NULL
low	NULL
pK	NULL
,	NULL
,	NULL
(	NULL
<	NULL
5	NULL
)	NULL
(	NULL
51	NULL
)	NULL
.	NULL

These	NULL
observations	NULL
thus	NULL
suggest	NULL
that	NULL
PTPases	NULL
may	NULL
constitute	NULL
targets	NULL
for	NULL
intracellularly	NULL
generated	NULL
H	NULL
;	NULL
0	NULL
,	NULL
and	NULL
that	NULL
their	NULL
inhibition	NULL
by	NULL
oxidants	NULL
may	NULL
well	NULL
lead	NULL
to	NULL
activation	NULL
of	NULL
number	NULL
of	NULL
signaling	NULL
molecules	NULL
,	NULL
such	NULL
as	NULL
STAT3	NULL
,	NULL
by	NULL
virtue	NULL
of	NULL
their	NULL
increased	NULL
phosphotyrosine	NULL
content	NULL
.	NULL

It	NULL
can	NULL
be	NULL
presumed	NULL
that	NULL
because	NULL
the	NULL
specific	NULL
activities	NULL
of	NULL
PTPases	NULL
in	NULL
vitro	NULL
are	NULL
10-1000	NULL
times	NULL
higher	NULL
than	NULL
those	NULL
of	NULL
PTKs	NULL
(	NULL
52	NULL
)	NULL
,	NULL
in	NULL
most	NULL
cell	NULL
17585	NULL
types	NULL
the	NULL
activation	NULL
of	NULL
a	NULL
receptor	NULL
tyrosine	NULL
kinase	NULL
upon	NULL
ligand	NULL
binding	NULL
may	NULL
not	NULL
be	NULL
sufficient	NULL
to	NULL
increase	NULL
the	NULL
steady-state	NULL
level	NULL
of	NULL
protein-tyrosine	NULL
phosphorylation	NULL
,	NULL
so	NULL
that	NULL
concurrent	NULL
inhibition	NULL
of	NULL
PTPases	NULL
by	NULL
H	NULL
,	NULL
O	NULL
and/or	NULL
derived	NULL
ROI	NULL
could	NULL
additionally	NULL
be	NULL
necessary	NULL
.	NULL

The	NULL
treatment	NULL
of	NULL
lymphocytes	NULL
with	NULL
vanadium	NULL
derivatives	NULL
induces	NULL
a	NULL
strong	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
protein	NULL
kinases	NULL
of	NULL
the	NULL
Erk2	NULL
and	NULL
Syk	NULL
families	NULL
,	NULL
leading	NULL
to	NULL
their	NULL
activation	NULL
(	NULL
45	NULL
)	NULL
.	NULL

Also	NULL
,	NULL
it	NULL
has	NULL
been	NULL
reported	NULL
that	NULL
treatment	NULL
of	NULL
blood	NULL
T	NULL
cells	NULL
elicits	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Lick	NULL
kinases	NULL
and	NULL
that	NULL
a	NULL
much	NULL
stronger	NULL
response	NULL
on	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
multiple	NULL
cellular	NULL
proteins	NULL
is	NULL
observed	NULL
following	NULL
treatment	NULL
with	NULL
the	NULL
sulfhydryl	NULL
oxidizing	NULL
agent	NULL
diamide	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
Sre	NULL
kinases	NULL
,	NULL
such	NULL
as	NULL
p56	NULL
``	NULL
**	NULL
and	NULL
p59	NULL
``	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
were	NULL
transiently	NULL
activated	NULL
by	NULL
H	NULL
,	NULL
O	NULL
,	NULL
in	NULL
combination	NULL
with	NULL
vanadate	NULL
(	NULL
23	NULL
)	NULL
.	NULL

It	NULL
is	NULL
interesting	NULL
to	NULL
note	NULL
that	NULL
vanadate	NULL
by	NULL
itself	NULL
exerts	NULL
a	NULL
limited	NULL
effect	NULL
on	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT3	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
this	NULL
work	NULL
.	NULL

However	NULL
,	NULL
upon	NULL
the	NULL
simultaneous	NULL
addition	NULL
of	NULL
H	NULL
;	NULL
0	NULL
;	NULL
and	NULL
vanadate	NULL
,	NULL
the	NULL
resulting	NULL
pervanadate	NULL
enhanced	NULL
severalfold	NULL
the	NULL
effects	NULL
exerted	NULL
separately	NULL
by	NULL
these	NULL
two	NULL
compounds	NULL
.	NULL

It	NULL
is	NULL
of	NULL
interest	NULL
that	NULL
pervanadate	NULL
administered	NULL
as	NULL
such	NULL
induces	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
nuclear	NULL
translocation	NULL
of	NULL
a	NULL
number	NULL
of	NULL
STAT	NULL
proteins	NULL
in	NULL
liver	NULL
cells	NULL
,	NULL
including	NULL
STAT3	NULL
(	NULL
53	NULL
)	NULL
.	NULL

Also	NULL
,	NULL
pervanadate	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
induce	NULL
T	NULL
cell	NULL
activation	NULL
and	NULL
transcription	NULL
of	NULL
c-fos	NULL
(	NULL
54	NULL
)	NULL
,	NULL
the	NULL
activation	NULL
of	NULL
interferon-y-	NULL
and	NULL
prolactin-dependent	NULL
transcription	NULL
factors	NULL
,	NULL
and	NULL
the	NULL
activation	NULL
of	NULL
JAK	NULL
kinases	NULL
in	NULL
epithelia	NULL
cells	NULL
(	NULL
55	NULL
,	NULL
56	NULL
)	NULL
.	NULL

The	NULL
possibility	NULL
that	NULL
the	NULL
H	NULL
,	NULL
O	NULL
,	NULL
and	NULL
pervanadate	NULL
effects	NULL
on	NULL
nuclear	NULL
translocation	NULL
of	NULL
STAT3	NULL
could	NULL
be	NULL
ascribed	NULL
to	NULL
inhibition	NULL
of	NULL
tyrosine	NULL
phosphatases	NULL
is	NULL
reinforced	NULL
by	NULL
experiments	NULL
using	NULL
PAO	NULL
and	NULL
diamide	NULL
,	NULL
two	NULL
compounds	NULL
able	NULL
to	NULL
act	NULL
as	NULL
PTPase	NULL
inhibitors	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
this	NULL
work	NULL
,	NULL
these	NULL
drugs	NULL
elicited	NULL
an	NULL
enhancement	NULL
of	NULL
the	NULL
H	NULL
,	NULL
O	NULL
,	NULL
action	NULL
,	NULL
whereas	NULL
genistein	NULL
,	NULL
an	NULL
inhibitor	NULL
of	NULL
protein-tyrosine	NULL
kinases	NULL
,	NULL
antagonized	NULL
the	NULL
H	NULL
;	NULL
O	NULL
;	NULL
and	NULL
diamide	NULL
effects	NULL
.	NULL

Genistein	NULL
did	NULL
not	NULL
,	NULL
however	NULL
,	NULL
counteract	NULL
the	NULL
increase	NULL
in	NULL
STAT3	NULL
phosphorylation	NULL
promoted	NULL
by	NULL
PAO	NULL
,	NULL
possibly	NULL
due	NULL
to	NULL
an	NULL
imbalance	NULL
between	NULL
the	NULL
phosphorylation	NULL
and	NULL
dephosphorylation	NULL
of	NULL
STAT3	NULL
at	NULL
the	NULL
study	NULL
doses	NULL
of	NULL
both	NULL
agents	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
present	NULL
results	NULL
are	NULL
in	NULL
line	NULL
with	NULL
previous	NULL
reports	NULL
,	NULL
demonstrating	NULL
that	NULL
H	NULL
;	NULL
0	NULL
,	NULL
acts	NULL
an	NULL
inhibitor	NULL
of	NULL
tyrosine	NULL
phosphatase	NULL
(	NULL
s	NULL
)	NULL
(	NULL
10-12	NULL
)	NULL
,	NULL
leading	NULL
in	NULL
turn	NULL
to	NULL
enhanced	NULL
STAT3	NULL
tyrosine	NULL
phosphorylation	NULL
.	NULL

The	NULL
complexity	NULL
of	NULL
this	NULL
phenomenon	NULL
is	NULL
evidenced	NULL
,	NULL
however	NULL
,	NULL
by	NULL
the	NULL
recent	NULL
demonstration	NULL
that	NULL
phosphorylation	NULL
of	NULL
STAT3	NULL
on	NULL
the	NULL
residue	NULL
Ser'*	NULL
``	NULL
is	NULL
also	NULL
required	NULL
for	NULL
competent	NULL
STAT3	NULL
transcriptional	NULL
activation	NULL
(	NULL
33	NULL
,	NULL
34	NULL
)	NULL
.	NULL

It	NULL
may	NULL
thus	NULL
be	NULL
speculated	NULL
that	NULL
H	NULL
;	NULL
O	NULL
;	NULL
could	NULL
as	NULL
well	NULL
increase	NULL
a	NULL
serine	NULL
kinase	NULL
activity	NULL
necessary	NULL
for	NULL
the	NULL
activation	NULL
of	NULL
STAT3	NULL
.	NULL

It	NULL
is	NULL
noteworthy	NULL
that	NULL
the	NULL
enhancing	NULL
effect	NULL
of	NULL
H	NULL
,	NULL
O	NULL
;	NULL
on	NULL
STAT3	NULL
nuclear	NULL
translocation	NULL
seems	NULL
rather	NULL
specific	NULL
,	NULL
because	NULL
neither	NULL
STAT1	NULL
nor	NULL
STAT5B	NULL
underwent	NULL
migration	NULL
to	NULL
the	NULL
nucleus	NULL
under	NULL
oxidative	NULL
conditions	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
this	NULL
paper	NULL
.	NULL

However	NULL
,	NULL
which	NULL
is	NULL
the	NULL
active	NULL
oxygen	NULL
species	NULL
directly	NULL
responsible	NULL
for	NULL
the	NULL
observed	NULL
H	NULL
;	NULL
0	NULL
,	NULL
effects	NULL
on	NULL
STAT3	NULL
activation	NULL
is	NULL
currently	NULL
unknown	NULL
.	NULL

Exogenously	NULL
H	NULL
;	NULL
0	NULL
;	NULL
,	NULL
added	NULL
is	NULL
rapidly	NULL
converted	NULL
into	NULL
other	NULL
chemical	NULL
species	NULL
,	NULL
and	NULL
in	NULL
this	NULL
context	NULL
we	NULL
present	NULL
evidence	NULL
,	NULL
using	NULL
a	NULL
combination	NULL
of	NULL
Fe	NULL
``	NULL
and	NULL
Cu®*	NULL
ions	NULL
,	NULL
that	NULL
'OH	NULL
radicals	NULL
generated	NULL
through	NULL
Fenton	NULL
reactions	NULL
could	NULL
fulfill	NULL
such	NULL
a	NULL
role	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
these	NULL
metal	NULL
ions	NULL
,	NULL
an	NULL
enhanced	NULL
STAT3	NULL
nuclear	NULL
translocation	NULL
and	NULL
DNA	NULL
binding	NULL
was	NULL
found	NULL
in	NULL
cells	NULL
exposed	NULL
to	NULL
H	NULL
;	NULL
0	NULL
,	NULL
.	NULL

Accordingly	NULL
,	NULL
it	NULL
is	NULL
clear	NULL
that	NULL
HO	NULL
;	NULL
is	NULL
not	NULL
the	NULL
sole	NULL
species	NULL
implicated	NULL
in	NULL
the	NULL
nuclear	NULL
translocation	NULL
of	NULL
STAT3	NULL
.	NULL

In	NULL
line	NULL
with	NULL
a	NULL
recent	NULL
paper	NULL
,	NULL
showing	NULL
that	NULL
1,10-phenantroline	NULL
,	NULL
a	NULL
chelator	NULL
of	NULL
iron	NULL
and	NULL
copper	NULL
ions	NULL
,	NULL
completely	NULL
prevented	NULL
DNA	NULL
strand	NULL
breakage	NULL
induced	NULL
by	NULL
H,0	NULL
,	NULL
(	NULL
57	NULL
)	NULL
,	NULL
we	NULL
have	NULL
found	NULL
that	NULL
this	NULL
compound	NULL
was	NULL
able	NULL
to	NULL
cancel	NULL
STAT3	NULL
nuclear	NULL
translocation	NULL
induced	NULL
by	NULL
H	NULL
;	NULL
0	NULL
,	NULL
.	NULL

These	NULL
results	NULL
speak	NULL
in	NULL
favor	NULL
of	NULL
the	NULL
possibility	NULL
that	NULL
in	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
17586	NULL
Oxidative	NULL
Stress	NULL
Activates	NULL
Lymphocyte	NULL
STAT3	NULL
tracellular	NULL
Fe	NULL
``	NULL
ions	NULL
could	NULL
play	NULL
a	NULL
role	NULL
as	NULL
intermediates	NULL
under	NULL
H,0	NULL
,	NULL
-induced	NULL
oxidative	NULL
stress	NULL
conditions	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
present	NULL
observations	NULL
support	NULL
a	NULL
role	NULL
for	NULL
oxidants	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
STAT3	NULL
transcription	NULL
factor	NULL
activity	NULL
in	NULL
vivo	NULL
in	NULL
human	NULL
lymphocytes	NULL
.	NULL

In	NULL
keeping	NULL
with	NULL
extensive	NULL
work	NULL
done	NULL
elsewhere	NULL
,	NULL
our	NULL
results	NULL
favor	NULL
the	NULL
hypothesis	NULL
that	NULL
H,0	NULL
,	NULL
by	NULL
itself	NULL
and/or	NULL
derived	NULL
oxidative	NULL
species	NULL
generated	NULL
through	NULL
Fenton	NULL
reactions	NULL
can	NULL
modulate	NULL
the	NULL
STAT3	NULL
tyrosine	NULL
phosphorylation	NULL
status	NULL
and	NULL
hence	NULL
promote	NULL
its	NULL
translocation	NULL
to	NULL
the	NULL
nucleus	NULL
and	NULL
the	NULL
formation	NULL
of	NULL
bound	NULL
complexes	NULL
at	NULL
specific	NULL
DNA	NULL
promoter	NULL
elements	NULL
.	NULL

Acknowledgment-We	NULL
thank	NULL
Dr.	NULL
O'Shea	NULL
for	NULL
kindly	NULL
providing	NULL
the	NULL
anti-STAT5B	NULL
antiserum	NULL
.	NULL

REFERENCES	NULL
.	NULL

Schreck	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Bacuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Trends	NULL
Cell	NULL
Biol	NULL
.	NULL

1	NULL
,	NULL
39-42	NULL
.	NULL

Schreck	NULL
,	NULL
R.	NULL
,	NULL
Rieber	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Bacuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

10	NULL
,	NULL
2247-2258	NULL
.	NULL

Burmell	NULL
,	NULL
J.	NULL
H.	NULL
,	NULL
Burkhardt	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
Bolen	NULL
,	NULL
B.	NULL
J.	NULL
,	NULL
and	NULL
Grinstein	NULL
,	NULL
S.	NULL
(	NULL
1996	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271	NULL
,	NULL
1455-1461	NULL
4	NULL
.	NULL

Curnutte	NULL
,	NULL
J.	NULL
T.	NULL
(	NULL
1998	NULL
)	NULL
Clin	NULL
.	NULL

Immunol	NULL
.	NULL

Immunopathol	NULL
.	NULL

67	NULL
,	NULL
(	NULL
suppl	NULL
.	NULL
)	NULL

2-15	NULL
5	NULL
.	NULL

Flescher	NULL
,	NULL
E.	NULL
,	NULL
Ledbetter	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Schieve	NULL
,	NULL
G.	NULL
L.	NULL
,	NULL
Vela-Roch	NULL
,	NULL
N.	NULL
,	NULL
Fossum	NULL
,	NULL
D.	NULL
,	NULL
Dang	NULL
,	NULL
H.	NULL
,	NULL
Ogawa	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Talal	NULL
,	NULL
N.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

153	NULL
,	NULL
4880-4889	NULL
.	NULL

Cerutti	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
Science	NULL
227	NULL
,	NULL
875-381	NULL
.	NULL

Cross	NULL
,	NULL
A.	NULL
R.	NULL
,	NULL
and	NULL
Jones	NULL
,	NULL
O.	NULL
T.	NULL
G.	NULL
(	NULL
1989	NULL
)	NULL
in	NULL
The	NULL
Neutrophil	NULL
:	NULL
Cellular	NULL
Biochemistry	NULL
and	NULL
Physiology	NULL
(	NULL
Hallet	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
ed	NULL
)	NULL
pp	NULL
.	NULL

97-111	NULL
,	NULL
CRC	NULL
Press	NULL
,	NULL
Inc.	NULL
,	NULL
Boca	NULL
Raton	NULL
,	NULL
FL	NULL
.	NULL

Halliwell	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Gutteridge	NULL
,	NULL
J.	NULL
M.	NULL
C.	NULL
(	NULL
1992	NULL
)	NULL
FEBS	NULL
Lett	NULL
.	NULL

807	NULL
,	NULL
108-112	NULL
.	NULL

Gunther	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
Hanna	NULL
,	NULL
P.	NULL
M.	NULL
,	NULL
Mason	NULL
,	NULL
R.	NULL
P.	NULL
,	NULL
and	NULL
Cohen	NULL
,	NULL
M.	NULL
S.	NULL
,	NULL
(	NULL
1995	NULL
)	NULL
Arch	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

816	NULL
,	NULL
515-522	NULL
10	NULL
.	NULL

Schieven	NULL
,	NULL
G.	NULL
L.	NULL
,	NULL
Kirihara	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Burg	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
Geahlen	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
and	NULL
Ledbetter	NULL
,	NULL
J	NULL
.	NULL

A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
16688-16692	NULL
11	NULL
.	NULL

Schieven	NULL
,	NULL
G.	NULL
L.	NULL
,	NULL
Mittler	NULL
,	NULL
R.	NULL
S.	NULL
,	NULL
Nadler	NULL
,	NULL
S.	NULL
G.	NULL
,	NULL
Kirihara	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Bolen	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
,	NULL
Kanner	NULL
,	NULL
S.	NULL
B.	NULL
,	NULL
and	NULL
Ledbetter	NULL
,	NULL
J	NULL
.	NULL

A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
20718-20726	NULL
12	NULL
.	NULL

Nakamura	NULL
,	NULL
K.	NULL
,	NULL
Hori	NULL
,	NULL
T.	NULL
,	NULL
Sato	NULL
,	NULL
N.	NULL
,	NULL
Sugie	NULL
,	NULL
K.	NULL
,	NULL
Kawakami	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Yodoi	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Oncogene	NULL
8	NULL
,	NULL
3133-3139	NULL
13	NULL
.	NULL

Bauskin	NULL
,	NULL
A.	NULL
R.	NULL
,	NULL
Alkalay	NULL
,	NULL
I.	NULL
,	NULL
and	NULL
Ben-Neriah	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Cell	NULL
66	NULL
,	NULL
685-696	NULL
14	NULL
.	NULL

Bernier	NULL
,	NULL
M.	NULL
,	NULL
Laird	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
and	NULL
Lane	NULL
,	NULL
M.	NULL
D.	NULL
(	NULL
1987	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

84	NULL
,	NULL
1844-1848	NULL
15	NULL
.	NULL

Lander	NULL
,	NULL
H.	NULL
M.	NULL
,	NULL
Levine	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
and	NULL
Novogrodsky	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Cell	NULL
Immunol	NULL
.	NULL

145	NULL
,	NULL
146-155	NULL
16	NULL
.	NULL

Oetken	NULL
,	NULL
C.	NULL
,	NULL
von	NULL
Willebrand	NULL
,	NULL
M.	NULL
,	NULL
Autero	NULL
,	NULL
M.	NULL
,	NULL
Ruutu	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Andersson	NULL
,	NULL
L.	NULL
C.	NULL
(	NULL
1992	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Haematol	NULL
.	NULL

49	NULL
,	NULL
208-214	NULL
17	NULL
.	NULL

Thle	NULL
J.	NULL
N.	NULL
,	NULL
Witthubn	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
Quelle	NULL
,	NULL
F.	NULL
W.	NULL
,	NULL
Yamamoto	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Silvennoinen	NULL
,	NULL
O	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

18	NULL
,	NULL
369-398	NULL
18	NULL
.	NULL

Schindler	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Darnell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Jr.	NULL
(	NULL
1995	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

64	NULL
,	NULL
621-651	NULL
19	NULL
.	NULL

Thle	NULL
,	NULL
J.	NULL
N.	NULL
(	NULL
1996	NULL
)	NULL
Cell	NULL
84	NULL
,	NULL
331-334	NULL
20	NULL
.	NULL

Watanabe	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Arai	NULL
,	NULL
K.	NULL
(	NULL
1996	NULL
)	NULL
Curr	NULL
.	NULL

Opin	NULL
.	NULL

Genet	NULL
.	NULL

Dev	NULL
.	NULL

6	NULL
,	NULL
587-596	NULL
21	NULL
.	NULL

Darnell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Jr.	NULL
(	NULL
1997	NULL
)	NULL
Science	NULL
277	NULL
,	NULL
1630-1635	NULL
22	NULL
.	NULL

Zhong	NULL
,	NULL
Z.	NULL
,	NULL
Wen	NULL
,	NULL
Z.	NULL
,	NULL
and	NULL
Darnell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Jr.	NULL
(	NULL
1994	NULL
)	NULL
Science	NULL
264	NULL
,	NULL
95-98	NULL
23	NULL
.	NULL

Schieven	NULL
,	NULL
G.	NULL
,	NULL
Kiribara	NULL
,	NULL
J.	NULL
,	NULL
Myers	NULL
,	NULL
D.	NULL
,	NULL
Ledbetter	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Ucken	NULL
,	NULL
F.	NULL
(	NULL
1993	NULL
)	NULL
Blood	NULL
82	NULL
,	NULL
1212-1220	NULL
24	NULL
.	NULL

Beiqing	NULL
,	NULL
L.	NULL
,	NULL
Chem	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Whisler	NULL
,	NULL
R.	NULL
L.	NULL
(	NULL
1996	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

157	NULL
,	NULL
160-169	NULL
to	NULL
bo	NULL
|A	NULL
~	NULL
o	NULL
t	NULL
o	NULL
25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

Hecht	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Zick	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

188	NULL
,	NULL
773-779	NULL
Zor	NULL
,	NULL
U.	NULL
,	NULL
Ferber	NULL
,	NULL
E.	NULL
,	NULL
Gergely	NULL
,	NULL
P.	NULL
,	NULL
Sziics	NULL
,	NULL
K.	NULL
,	NULL
Dombradi	NULL
,	NULL
V.	NULL
,	NULL
and	NULL
Goldman	NULL
,	NULL
R.	NULL
(	NULL
1993	NULL
)	NULL
Biochem	NULL
.	NULL

J	NULL
.	NULL

295	NULL
,	NULL
879-888	NULL
Fialkow	NULL
,	NULL
L.	NULL
,	NULL
Chan	NULL
,	NULL
C.	NULL
K.	NULL
,	NULL
Rotin	NULL
,	NULL
D.	NULL
,	NULL
Grinstein	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Downey	NULL
,	NULL
G.	NULL
P.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
81284-31242	NULL
Darnell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Jr.	NULL
,	NULL
Kerr	NULL
,	NULL
I.	NULL
M.	NULL
,	NULL
and	NULL
Stark	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1994	NULL
)	NULL
Science	NULL
264	NULL
,	NULL
1415-1421	NULL
Taniguchi	NULL
,	NULL
T.	NULL
(	NULL
1995	NULL
)	NULL
Science	NULL
268	NULL
,	NULL
251-255	NULL
Thle	NULL
,	NULL
J.	NULL
N.	NULL
(	NULL
1995	NULL
)	NULL
Nature	NULL
877	NULL
,	NULL
591-594	NULL
Ivashkiv	NULL
,	NULL
L.	NULL
B	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Immunity	NULL
8	NULL
,	NULL
1-4	NULL
Zhang	NULL
,	NULL
X.	NULL
,	NULL
Blenis	NULL
,	NULL
J.	NULL
,	NULL
Li	NULL
,	NULL
H.-C.	NULL
,	NULL
Schindler	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Chen-Kiang	NULL
,	NULL
S.	NULL
(	NULL
1995	NULL
)	NULL
Science	NULL
267	NULL
,	NULL
1990-1994	NULL
Ng	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Cantrell	NULL
,	NULL
D.	NULL
(	NULL
1997	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

2728	NULL
,	NULL
24542-24549	NULL
Wen	NULL
,	NULL
Z.	NULL
,	NULL
Zhong	NULL
,	NULL
Z.	NULL
,	NULL
and	NULL
Darnell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Jr.	NULL
(	NULL
1995	NULL
)	NULL
Cell	NULL
82	NULL
,	NULL
241-250	NULL
Coligan	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Kruisbeck	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Margulies	NULL
,	NULL
D.	NULL
H.	NULL
,	NULL
Shevach	NULL
,	NULL
E.	NULL
M.	NULL
,	NULL
and	NULL
Strober	NULL
,	NULL
W.	NULL
(	NULL
eds	NULL
)	NULL
(	NULL
1993	NULL
)	NULL
Current	NULL
Protocols	NULL
in	NULL
Immunology	NULL
,	NULL
p.	NULL
8.0.1	NULL
,	NULL
Greene	NULL
Publishing	NULL
Associates	NULL
,	NULL
New	NULL
York	NULL
Carballo	NULL
,	NULL
M.	NULL
,	NULL
Marquez	NULL
,	NULL
G.	NULL
,	NULL
Conde	NULL
,	NULL
M.	NULL
,	NULL
Martin-Nieto	NULL
,	NULL
J.	NULL
,	NULL
Monteseirin	NULL
,	NULL
J.	NULL
Conde	NULL
,	NULL
J.	NULL
,	NULL
Pintado	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Sobrino	NULL
,	NULL
F.	NULL
(	NULL
1999	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

274	NULL
,	NULL
93-100	NULL
Johnston	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Bacon	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Finbloom	NULL
,	NULL
D.	NULL
S.	NULL
,	NULL
Rees	NULL
,	NULL
R.	NULL
C.	NULL
,	NULL
Kaplan	NULL
,	NULL
D.	NULL
,	NULL
Shibuya	NULL
,	NULL
L.	NULL
,	NULL
Ortaldo	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
Gupta	NULL
,	NULL
S.	NULL
,	NULL
Chen	NULL
,	NULL
Y.	NULL
Q.	NULL
,	NULL
Giri	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
and	NULL
O'Shea	NULL
,	NULL
J.	NULL
J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

92	NULL
,	NULL
8705-8709	NULL
O'Shea	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
McVicar	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Bailey	NULL
,	NULL
T.	NULL
L.	NULL
,	NULL
Burns	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Smyth	NULL
,	NULL
M.	NULL
J	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sei	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

89	NULL
,	NULL
10306-10810	NULL
Garcia-Morales	NULL
,	NULL
P.	NULL
,	NULL
Minami	NULL
,	NULL
Y.	NULL
,	NULL
Luong	NULL
,	NULL
E.	NULL
,	NULL
Klausner	NULL
,	NULL
R.	NULL
D.	NULL
,	NULL
and	NULL
Samelson	NULL
,	NULL
L.	NULL
E.	NULL
(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

87	NULL
,	NULL
9255-9259	NULL
Fialkow	NULL
,	NULL
L.	NULL
,	NULL
Chan	NULL
,	NULL
C.	NULL
K.	NULL
,	NULL
Grinstein	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Downey	NULL
,	NULL
G.	NULL
P.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
17131-17137	NULL
Tian	NULL
S.-S.	NULL
Tapley	NULL
,	NULL
P.	NULL
,	NULL
Sincich	NULL
,	NULL
C.	NULL
,	NULL
Stein	NULL
,	NULL
R.	NULL
B.	NULL
,	NULL
Rosen	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Lamb	NULL
,	NULL
P.	NULL
(	NULL
1996	NULL
)	NULL
Blood	NULL
12	NULL
,	NULL
4485-4444	NULL
De	NULL
Koning	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Dong	NULL
,	NULL
F.	NULL
,	NULL
Smith	NULL
,	NULL
L.	NULL
,	NULL
Schelen	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Barge	NULL
,	NULL
R.	NULL
M.	NULL
Y.	NULL
,	NULL
van	NULL
der	NULL
Plas	NULL
,	NULL
D.	NULL
C.	NULL
,	NULL
Hoefsloot	NULL
,	NULL
L.	NULL
H.	NULL
,	NULL
Lowenberg	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Touw	NULL
,	NULL
I.	NULL
P.	NULL
(	NULL
1996	NULL
)	NULL
Blood	NULL
87	NULL
,	NULL
1335-1342	NULL
Sadowski	NULL
,	NULL
H.	NULL
B.	NULL
,	NULL
Shuai	NULL
,	NULL
K.	NULL
,	NULL
Darnell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Jr.	NULL
,	NULL
and	NULL
Gilman	NULL
,	NULL
M.	NULL
Z	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Science	NULL
261	NULL
,	NULL
1739-1744	NULL
Wagner	NULL
,	NULL
B.	NULL
J.	NULL
,	NULL
Hayes	NULL
,	NULL
T.	NULL
E.	NULL
,	NULL
Hoban	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
and	NULL
Cochran	NULL
,	NULL
B.	NULL
H.	NULL
(	NULL
1990	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

9	NULL
,	NULL
4477-4484	NULL
Krejsa	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Nadler	NULL
,	NULL
S.	NULL
G.	NULL
,	NULL
Esselstyn	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Kavanagh	NULL
,	NULL
T.	NULL
J.	NULL
,	NULL
Ledbetter	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Schieven	NULL
,	NULL
G.	NULL
L.	NULL
(	NULL
1997	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272	NULL
,	NULL
11541-11549	NULL
Singh	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Aggarwal	NULL
,	NULL
B	NULL
.	NULL

B	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
10631-10639	NULL
Lahdenpohja	NULL
,	NULL
N.	NULL
,	NULL
Savinainen	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Hurme	NULL
,	NULL
M.	NULL
(	NULL
1998	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

160	NULL
,	NULL
1354-1358	NULL
Brunn	NULL
,	NULL
G.	NULL
J.	NULL
,	NULL
Falls	NULL
,	NULL
E.	NULL
L.	NULL
,	NULL
Nilson	NULL
,	NULL
A.	NULL
E.	NULL
,	NULL
and	NULL
Abraham	NULL
,	NULL
R.	NULL
T.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
11628-11635	NULL
Goldkorn	NULL
,	NULL
T.	NULL
,	NULL
Balaban	NULL
,	NULL
N.	NULL
,	NULL
Matsukuma	NULL
,	NULL
K.	NULL
,	NULL
Chea	NULL
,	NULL
V.	NULL
,	NULL
Gould	NULL
,	NULL
R.	NULL
,	NULL
Last	NULL
,	NULL
J.	NULL
,	NULL
Chan	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Chavez	NULL
,	NULL
C.	NULL
(	NULL
1998	NULL
)	NULL
Am	NULL
.	NULL

J.	NULL
Respir	NULL
.	NULL

Cell	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

19	NULL
,	NULL
786-798	NULL
Heffetz	NULL
,	NULL
D.	NULL
,	NULL
Bushkin	NULL
,	NULL
L	NULL
,	NULL
Dror	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Zick	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265	NULL
,	NULL
2896-2902	NULL
Stone	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
and	NULL
Dixon	NULL
,	NULL
J.	NULL
E.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
81323-31326	NULL
Fischer	NULL
,	NULL
E.	NULL
H.	NULL
,	NULL
Charbonneau	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Tonks	NULL
,	NULL
N.	NULL
K.	NULL
(	NULL
1991	NULL
)	NULL
Science	NULL
258	NULL
,	NULL
401-406	NULL
Ruff	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
Chem	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Cohen	NULL
,	NULL
S.	NULL
(	NULL
1997	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272	NULL
,	NULL
1263-1267	NULL
Imbert	NULL
,	NULL
V.	NULL
,	NULL
Peyron	NULL
,	NULL
J.	NULL
F.	NULL
,	NULL
Farahi	NULL
,	NULL
F.	NULL
D.	NULL
,	NULL
Mari	NULL
,	NULL
B.	NULL
,	NULL
Auberger	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Rossi	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Biochem	NULL
.	NULL

J	NULL
.	NULL

297	NULL
,	NULL
168-173	NULL
Lamb	NULL
,	NULL
P.	NULL
,	NULL
Haslam	NULL
,	NULL
J.	NULL
,	NULL
Kessler	NULL
,	NULL
L.	NULL
,	NULL
Seidel	NULL
,	NULL
H.	NULL
M.	NULL
,	NULL
Stein	NULL
,	NULL
R.	NULL
B.	NULL
,	NULL
and	NULL
Rosen	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
J.	NULL
Interferon	NULL
Res	NULL
.	NULL

14	NULL
,	NULL
365-878	NULL
Tourkine	NULL
,	NULL
N.	NULL
,	NULL
Schindler	NULL
,	NULL
C.	NULL
,	NULL
Larose	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Houdebine	NULL
,	NULL
L.	NULL
M.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
20952-20961	NULL
Jornot	NULL
,	NULL
L.	NULL
,	NULL
Petersen	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Junod	NULL
,	NULL
A.	NULL
F.	NULL
(	NULL
1998	NULL
)	NULL
Biochem	NULL
.	NULL

J	NULL
.	NULL

885	NULL
,	NULL
85-94	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
Oxidative	NULL
Stress	NULL
Triggers	NULL
STAT3	NULL
Tyrosine	NULL
Phosphorylation	NULL
and	NULL
Nuclear	NULL
Translocation	NULL
in	NULL
Human	NULL
Lymphocytes	NULL
Modesto	NULL
Carballo	NULL
,	NULL
Manuel	NULL
Conde	NULL
,	NULL
Rajaa	NULL
El	NULL
Bekay	NULL
,	NULL
Jose	NULL
Marti	NULL
?	NULL

n-Nieto	NULL
,	NULL
Mari	NULL
?	NULL

a	NULL
Jesus	NULL
Camacho	NULL
,	NULL
Javier	NULL
Monteseiri	NULL
?	NULL

n	NULL
,	NULL
José	NULL
Conde	NULL
,	NULL
Francisco	NULL
J.	NULL
Bedoya	NULL
and	NULL
Francisco	NULL
Sobrino	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

1999	NULL
,	NULL
274:17580-17586.	NULL
doi	NULL
:	NULL
10.1074/jb0.274.25.17580	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
http	NULL
:	NULL
/www.jbe.org/content/274/25/17580	NULL
Alerts	NULL
:	NULL
«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
55	NULL
references	NULL
,	NULL
34	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
7580	NULL
.full.html	NULL
#	NULL
ref-list-1	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL

